Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40759040	s-c-pep-a	nmol/l (nmol/l)	2002	2482	0.00%
40759040	p-c-pepta	nmol/l (nmol/l)	1073	1442	1.25%
40759040	s-c-pep-a	— (—)	320	417	100.00%	Distribution not available
40759040	p-c-pepta	— (—)	118	134	100.00%	Distribution not available
40759040	s-c-peptidi1haterianjälkeen	nmol/l (nmol/l)	95	99	0.00%
40759040	s-c-pepaj	nmol/l (nmol/l)	54	64	0.00%
40759040	s-c-peptidi1haterianjäkeen	nmol/l (nmol/l)	36	39	0.00%
40759040	c-pepta	nmol/l (nmol/l)	10	13	0.00%	Distribution not available
40759040	s-c-pepaj	— (—)	5	7	100.00%	Distribution not available
40759040	s-c-peptidi1haterianjälkeen	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Sub-endpoint used in defining T1D endpoints

658

821

8.18

307.65

1.4

1.3

0.81

1.55

nmol/l

47.13

547

753

Diabetes, varying definitions

2273

211

65.37

307.65

1.3

2.0

1.43

1.41

nmol/l

0.11

2051

191

Diabetes mellitus

2300

188

74.04

307.65

1.3

2.1

1.43

1.47

nmol/l

0.22

2073

173

Insulin, combination of fast acting with intermediate-acting or long-acting

2493

713

34.36

307.65

1.3

1.26

1.81

nmol/l

29.41

2243

653

Diabetes medication

2437

247

60.68

307.65

1.3

2.0

1.43

1.44

nmol/l

0.05

2197

228

Insulin, fast-acting

1486

411

39.20

307.65

1.4

1.03

1.74

nmol/l

27.71

1307

372

Statin medication

736

595

7.05

307.65

1.3

1.5

1.47

1.31

nmol/l

2.34

656

547

Insulin medication

2492

181

124.78

307.65

1.3

1.8

1.26

1.47

nmol/l

1.95

2242

168

Type 2 diabetes, definitions combined, including avohilmo

1836

193

57.10

307.65

1.3

2.0

1.60

1.30

nmol/l

3.63

1694

180

Biguanides

2176

468

29.38

307.65

1.3

1.7

1.50

1.13

nmol/l

11.00

1991

408

Type 2 diabetes, strict (exclude DM1)

1883

207

55.11

307.65

1.3

2.0

1.59

1.36

nmol/l

2.24

1738

193

Insulin, fast-acting or short human

1490

796

20.21

307.65

1.4

1.3

1.03

1.67

nmol/l

41.65

1311

726

Type 2 diabetes

2182

173

76.31

307.65

1.3

2.1

1.48

1.43

nmol/l

0.23

1975

160

Any reimbursement code in KELA

503

159

16.03

307.65

1.4

1.8

1.36

1.54

nmol/l

1.08

451

148

Combinations of oral blood glucose lowering drugs

782

193

43.04

307.65

1.3

1.6

1.44

1.15

nmol/l

3.01

718

168

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1124

208

58.77

307.65

1.3

1.7

1.68

1.16

nmol/l

8.99

1052

178

Diabetes, insulin treatment (Kela reimbursement)

2547

288

55.62

307.65

1.3

1.8

1.42

1.52

nmol/l

0.84

2289

268

Other (not insulin) diabetes medications

2229

229

59.90

307.65

1.3

2.0

1.51

1.42

nmol/l

0.63

2030

213

Sulfonylureas

797

135

49.17

307.65

1.2

1.4

1.20

1.18

nmol/l

0.08

725

112

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1631

276

50.13

307.65

1.3

1.6

1.52

1.13

nmol/l

7.62

1496

238

Endocrine, nutritional and metabolic diseases

945

52.30

307.65

1.4

1.3

1.40

1.51

nmol/l

0.37

855

Insulin, intermediate and long-acting

2321

664

36.79

307.65

1.3

1.24

1.79

nmol/l

29.27

2077

609

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2451

163

94.42

307.65

1.3

2.0

1.42

1.45

nmol/l

0.13

2202

151

Type 2 diabetes, wide definition

1886

249

50.49

307.65

1.3

1.7

1.48

1.03

nmol/l

10.72

1713

220

Type 1 diabetes

632

95.96

307.65

1.4

2.2

0.81

1.50

nmol/l

5.40

520

Thiazolidinediones

323

52.46

307.65

1.3

1.7

1.37

1.27

nmol/l

0.25

298

Type 2 diabetes, definitions combined

1882

157

72.63

307.65

1.2

2.2

1.59

1.44

nmol/l

0.99

1737

145

Type 1 diabetes, wide definition

512

89.16

307.65

1.4

2.1

0.75

1.59

nmol/l

6.02

416

Other blood glucose lowering drugs, excl. Insulins

470

59.79

307.65

1.3

1.7

1.44

1.29

nmol/l

0.47

416

Glucagon-like peptide-1 (GLP-1) analogues

1124

208

58.77

307.65

1.3

1.7

1.68

1.16

nmol/l

8.99

1052

178

Cardiac arrhythmias

359

106

22.20

307.65

1.4

2.3

1.66

1.44

nmol/l

0.99

329

Chronic pancreatitis

351

412

9.05

277.44

1.4

1.3

0.93

1.51

nmol/l

15.06

313

369

Obesity

795

1999

3.90

262.07

1.4

1.3

1.72

1.35

nmol/l

12.49

734

1794

Obesity and other hyperalimentation

797

2006

3.89

261.72

1.4

1.3

1.71

1.35

nmol/l

12.49

736

1800

Other nutritional deficiencies

803

2074

3.70

244.13

1.5

1.3

1.71

1.35

nmol/l

12.99

740

1862

Hypertension, essential

799

1138

4.02

229.34

1.4

1.61

1.30

nmol/l

8.43

707

1026

Hypertension

807

1167

3.95

226.10

1.4

1.62

1.30

nmol/l

8.82

714

1049

Hypertensive diseases

807

1169

3.94

225.68

1.4

1.62

1.31

nmol/l

8.66

714

1051

Hypertensive diseases (excluding secondary)

590

718

4.84

212.05

1.4

1.60

1.27

nmol/l

7.13

523

651

Obesity due to excess calories

592

1486

4.06

208.08

1.5

1.3

1.76

1.35

nmol/l

11.68

544

1321

Special screening examination for other diseases and disorders

243

261

9.68

204.74

1.2

1.70

1.47

nmol/l

1.74

219

236

Obesity, other/unspecified

453

992

4.66

190.47

1.6

1.3

1.72

1.42

nmol/l

5.13

423

883

Acute pancreatitis

331

597

5.71

174.65

1.4

1.3

1.13

1.49

nmol/l

6.51

300

533

Metabolic disorders

932

1992

2.88

168.41

1.3

1.43

nmol/l

0.03

837

1799

Disorders of gallbladder, biliary tract and pancreas

972

2238

2.77

164.70

1.3

1.33

1.48

nmol/l

3.46

882

2020

Alcohol-induced chronic pancreatitis

189

215

9.42

153.53

1.5

1.2

0.88

1.47

nmol/l

8.51

170

194

Acute pancreatitis (for exclusion)

331

674

5.06

152.51

1.4

1.3

1.13

1.50

nmol/l

6.95

300

600

Autoimmune diseases excluding thyroid diseases

956

1968

2.67

145.71

1.4

1.3

1.20

1.51

nmol/l

13.10

843

1825

Disorders of lipoprotein metabolism and other lipidaemias

804

1767

2.85

142.84

1.3

1.47

1.42

nmol/l

0.55

718

1592

Autoimmune diseases excluding thyroid diseases, strict definition

920

1912

2.66

138.87

1.4

1.3

1.18

1.51

nmol/l

14.34

807

1770

Other disorders of glucose regulation and pancreatic internal secretion

181

239

7.91

129.50

2.4

1.3

1.00

1.38

nmol/l

3.83

159

215

Heart failure and antihypertensive medication

229

210

7.24

126.68

1.3

1.4

1.73

1.16

nmol/l

7.29

201

189

Diabetes mellitus in pregnancy

307

379

5.26

125.93

1.5

1.4

1.50

1.42

nmol/l

0.45

281

341

Antihypertensive medication - note that there are other indications

451

614

3.92

122.91

1.4

1.5

1.47

1.25

nmol/l

3.06

405

568

Heart failure, not strict

725

1839

2.71

120.69

1.3

1.60

1.37

nmol/l

4.88

634

1680

Insulin, fast-acting (human)

134

137

9.95

116.77

1.4

1.5

0.83

1.78

nmol/l

11.71

123

Tramadol

722

1660

2.70

116.19

1.4

1.3

1.48

1.38

nmol/l

1.31

656

1500

Elevated blood glucose level

176

257

7.16

115.19

1.5

1.4

1.16

1.48

nmol/l

2.53

154

229

Autoimmune diseases

933

1977

2.42

114.29

1.3

1.29

1.51

nmol/l

6.43

822

1834

Diseases of arteries, arterioles and capillaries (FINNGEN)

258

337

5.38

112.11

1.3

1.4

1.42

1.24

nmol/l

1.28

228

311

Hypoglycaemia, other or unspecified

149

188

8.30

110.89

2.7

1.3

1.04

1.39

nmol/l

2.42

130

169

Continuous positive airway pressure

32.74

110.49

1.2

1.8

1.40

1.41

nmol/l

0.02

Cardiovascular diseases (excluding rheumatic etc)

507

906

3.24

109.49

1.4

1.50

1.29

nmol/l

3.46

452

828

Gestational diabetes (for exclusion)

321

524

4.31

109.39

1.5

1.4

1.46

1.48

nmol/l

0.07

298

468

All chronic kidney diseases

523

1453

2.98

108.95

1.3

1.54

1.37

nmol/l

2.37

466

1313

All kidney diseases

846

2468

2.36

107.10

1.3

1.54

1.40

nmol/l

2.48

759

2236

Pure hypercholesterolaemia

656

1661

2.60

100.40

1.3

1.45

1.44

nmol/l

0.10

590

1492

Other bacterial diseases

856

2401

2.28

98.26

1.4

1.3

1.48

1.40

nmol/l

1.06

767

2178

Persons encountering health services for other counselling and medical advice, not elsewhere classified

932

2283

2.23

97.99

1.4

1.3

1.45

1.43

nmol/l

0.23

841

2070

Used for control exclusion in common control thyroid runs

852

1858

2.33

96.66

1.3

1.31

1.51

nmol/l

5.01

751

1721

Renal tubulo-interstitial diseases

742

2360

2.36

95.94

1.3

1.55

1.40

nmol/l

2.48

669

2132

General examination and investigation of persons without complaint and reported diagnosis

587

1112

2.78

94.92

1.4

1.3

1.62

1.41

nmol/l

3.72

540

1005

Coronary revascularization (ANGIO or CABG)

697

1741

2.47

94.65

1.3

1.55

1.36

nmol/l

4.17

629

1572

Percutaneous Coronary Intervention

695

1740

2.47

94.19

1.3

1.56

1.36

nmol/l

4.31

628

1571

Other diseases of pancreas

155

246

6.56

93.74

1.3

1.07

1.52

nmol/l

4.43

138

219

Other retinal disorders

581

1753

2.61

93.61

1.3

1.16

1.48

nmol/l

10.67

479

1609

Alcohol use disorder, Swedish definition

542

1925

2.61

90.72

1.3

1.32

1.43

nmol/l

1.32

490

1737

Ischemic heart diseases

713

1805

2.39

89.86

1.3

1.55

1.36

nmol/l

3.63

638

1629

Other bacterial diseases

797

2421

2.23

88.27

1.4

1.3

1.48

1.41

nmol/l

0.90

718

2190

Emergency coronary revascularization (for ACS)

720

1885

2.34

86.89

1.3

1.54

1.37

nmol/l

3.66

651

1699

Hard cardiovascular diseases

700

1781

2.36

85.76

1.3

1.4

1.54

1.36

nmol/l

3.58

633

1600

Coronary atherosclerosis

578

1437

2.57

85.67

1.3

1.54

1.36

nmol/l

3.06

518

1295

Peripheral artery disease

429

1189

2.91

85.24

1.3

1.2

1.37

1.39

nmol/l

0.18

376

1072

Persons encountering health services in other circumstances, wide

929

2283

2.11

83.73

1.4

1.3

1.42

1.43

nmol/l

0.12

838

2070

Major coronary heart disease event

706

1853

2.32

83.22

1.3

1.55

1.36

nmol/l

3.88

635

1672

568

2073

2.44

81.79

1.3

1.32

1.44

nmol/l

1.71

515

1874

546

2027

2.46

80.59

1.3

1.31

1.44

nmol/l

1.94

495

1833

STROKE

356

776

3.14

77.60

1.3

1.52

1.47

nmol/l

0.31

310

704

Diseases of liver

356

1229

2.94

76.09

1.3

1.53

1.42

nmol/l

0.95

319

1098

Glomerular disorders in diseases classified elsewhere

176

387

4.68

74.25

1.4

1.3

1.39

1.49

nmol/l

0.44

147

341

Renal failure

417

1394

2.67

72.86

1.3

1.61

1.38

nmol/l

2.80

374

1264

Ischaemic heart disease, wide definition

646

1787

2.26

72.29

1.3

1.54

1.39

nmol/l

2.57

577

1609

Cardiovascular diseases

423

825

2.77

69.27

1.4

1.51

1.28

nmol/l

3.54

377

756

Explicit Sepsis

386

1367

2.66

67.87

1.3

1.53

1.40

nmol/l

1.22

345

1238

Hypertensive Heart Disease

196

370

4.20

67.67

1.4

1.3

1.68

1.22

nmol/l

4.73

175

333

Hypertensive heart and/or renal disease

211

400

3.98

66.92

1.4

1.3

1.65

1.23

nmol/l

4.53

188

360

Septicaemia

368

1301

2.67

65.22

1.3

1.2

1.51

1.40

nmol/l

1.12

330

1180

Other septicaemia

328

1138

2.80

64.03

1.3

1.2

1.49

1.38

nmol/l

0.99

300

1030

Nerve, nerve root and plexus disorders

815

2560

1.96

63.64

1.4

1.3

1.48

1.42

nmol/l

0.83

737

2311

Disorders of choroid and retina

645

2186

2.11

63.58

1.3

1.21

1.48

nmol/l

8.50

538

2007

Other heart diseases

323

718

2.96

63.06

1.4

1.55

1.25

nmol/l

3.98

293

653

Erysipelas

581

2064

2.16

61.96

1.3

1.53

1.40

nmol/l

1.95

525

1868

Chronic kidney disease

279

946

2.93

59.31

1.3

1.65

1.37

nmol/l

2.90

247

849

Malignant neoplasm of pancreas, including Hilmo

132

280

4.86

58.31

1.3

1.20

1.46

nmol/l

1.62

118

247

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

737

2624

1.95

58.10

1.4

1.3

1.46

1.43

nmol/l

0.31

666

2371

Ulcer of lower limb, not elsewhere classified

175

461

3.88

58.07

1.3

1.30

1.45

nmol/l

0.80

147

407

Obesity related asthma

322

1218

2.68

57.97

1.4

1.3

1.74

1.41

nmol/l

4.69

303

1092

Substance abuse, excluding more controls

467

1763

2.28

57.62

1.4

1.3

1.37

1.40

nmol/l

0.22

420

1584

Glomerular diseases

206

609

3.44

57.49

1.4

1.3

1.43

1.48

nmol/l

0.21

174

543

Mood disorders, excluding more controls

703

2116

1.99

57.30

1.4

1.3

1.51

1.41

nmol/l

1.39

647

1903

Parasetamol

544

1236

2.24

57.01

1.4

1.3

1.44

1.31

nmol/l

1.74

489

1127

Infections of the skin and subcutaneous tissue

482

2184

2.20

56.60

1.4

1.3

1.40

1.42

nmol/l

0.09

441

1969

Examination and observation for other reasons

450

1108

2.37

55.23

1.3

1.37

1.41

nmol/l

0.33

406

1001

Alcohol-induced acute pancreatitis

128

7.01

54.38

1.4

1.2

0.78

1.45

nmol/l

6.21

116

Codeine

650

1754

2.02

53.92

1.4

1.3

1.45

1.38

nmol/l

0.72

583

1588

Other disorders of fluid, electrolyte and acid-base balance

253

834

2.92

53.32

1.4

1.2

1.30

1.41

nmol/l

0.86

228

751

Implicit Sepsis

611

2243

2.00

52.83

1.3

1.48

1.41

nmol/l

0.82

542

2032

Atherosclerosis, excluding cerebral and coronary sclerosis

346

1097

2.52

52.65

1.3

1.2

1.37

1.40

nmol/l

0.18

308

989

Condition for Implicit Sepsis (Organ dysfunction codes)

659

2340

1.95

52.37

1.4

1.3

1.46

1.42

nmol/l

0.35

587

2123

Influenza and pneumonia

767

2637

1.86

51.72

1.4

1.3

1.48

1.41

nmol/l

0.89

701

2382

Atrial fibrillation and flutter with reimbursement

192

338

3.65

51.36

1.4

1.57

1.26

nmol/l

2.41

176

311

Sleep apnoea, including avohilmo

731

2413

1.89

51.27

1.3

1.70

1.35

nmol/l

11.58

674

2168

Sleep apnoea

699

2388

1.91

51.04

1.3

1.70

1.35

nmol/l

10.23

644

2150

Fever of other and unknown origin

433

1747

2.22

51.02

1.3

1.54

1.41

nmol/l

1.44

400

1577

Opioids

668

1770

1.97

50.90

1.4

1.3

1.51

1.39

nmol/l

1.86

594

1603

Mood [affective] disorders

749

2627

1.86

50.62

1.4

1.3

1.51

1.41

nmol/l

1.65

689

2361

Nausea and vomiting

223

729

3.03

50.53

1.5

1.2

1.37

1.44

nmol/l

0.44

199

646

Chronic apical periodontitis

799

2493

1.83

50.42

1.4

1.3

1.45

1.43

nmol/l

0.17

711

2264

Mood disorders

750

2631

1.85

50.39

1.4

1.3

1.51

1.41

nmol/l

1.64

689

2366

Implicit bacterial Sepsis

360

1308

2.40

50.23

1.3

1.50

1.40

nmol/l

0.80

322

1190

Angina pectoris

436

1295

2.26

50.22

1.3

1.56

1.35

nmol/l

3.00

398

1179

Cutaneous abscess, furuncle and carbuncle

242

852

2.88

50.11

1.4

1.3

1.40

1.46

nmol/l

0.36

221

763

Cholelithiasis, broad definition with cholecystitis

599

2039

1.99

49.90

1.3

1.50

1.47

nmol/l

0.20

541

1845

Certain infectious and parasitic diseases

694

1806

1.93

49.72

1.4

1.3

1.49

1.40

nmol/l

1.07

616

1659

Other diseases of liver

187

571

3.33

49.61

1.3

1.68

1.46

nmol/l

1.59

161

510

Cerebrovascular diseases (FINNGEN)

217

484

3.20

49.50

1.3

1.4

1.55

1.27

nmol/l

2.59

193

432

Peripheral artery operations in Hilmo

144

370

3.96

49.48

1.3

1.23

1.37

nmol/l

0.87

125

319

Amputation

128

302

4.33

49.43

1.3

1.33

1.48

nmol/l

0.72

112

263

Implicit Sepsis

560

2113

2.01

49.35

1.3

1.49

1.41

nmol/l

0.79

499

1913

Persons encountering health services for specific procedures and health care

779

2566

1.83

49.34

1.3

1.4

1.44

1.42

nmol/l

0.23

691

2342

Diseases of arteries, arterioles and capillaries

516

1848

2.08

49.33

1.3

1.43

1.42

nmol/l

0.08

458

1674

Bacterial Sepsis

373

1377

2.33

48.93

1.3

1.47

1.39

nmol/l

0.64

330

1253

Cholelithiasis

575

1998

1.99

48.65

1.3

1.51

1.47

nmol/l

0.33

520

1806

Other maternal disorders predominantly related to pregnancy

346

888

2.46

47.31

1.5

1.4

1.50

nmol/l

0.02

321

795

Abdominal and pelvic pain

718

1931

1.88

47.19

1.4

1.3

1.38

1.42

nmol/l

0.43

652

1743

Condition for Implicit Sepsis (Organ dysfunction codes)

617

2285

1.92

46.76

1.3

1.46

1.41

nmol/l

0.42

546

2071

Implicit bacterial Sepsis

327

1210

2.42

46.73

1.3

1.47

1.40

nmol/l

0.45

292

1097

Erysipelas

438

1829

2.13

46.67

1.4

1.3

1.55

1.39

nmol/l

2.13

397

1651

L04AD Calcineurin inhibitors

134

342

4.01

46.62

1.4

1.3

1.41

1.44

nmol/l

0.12

118

310

Depression

687

2527

1.85

46.52

1.4

1.3

1.50

1.40

nmol/l

1.44

629

2273

Transplanted organ and tissue status

127

313

4.15

46.36

1.4

1.3

1.44

nmol/l

0.02

109

277

Kidney transplant status

147

5.92

46.15

1.5

1.4

1.41

1.42

nmol/l

0.02

135

Intestinal malabsorption

124

6.43

46.02

1.5

1.3

0.92

1.47

nmol/l

3.57

112

Personality disorders, excluding more controls

216

750

2.91

45.85

1.4

1.3

1.62

1.41

nmol/l

1.86

202

673

Acute tubulo-interstitial nephritis

446

1838

2.11

45.82

1.3

1.50

1.42

nmol/l

0.91

401

1661

Malaise and fatigue

391

1419

2.23

45.79

1.3

1.40

1.44

nmol/l

0.26

351

1277

Atrial fibrillation and flutter

214

448

3.12

45.78

1.3

1.4

1.56

1.25

nmol/l

2.67

193

406

638

2042

1.90

45.69

1.4

1.3

1.48

1.39

nmol/l

1.15

582

1849

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

638

2042

1.90

45.69

1.4

1.3

1.48

1.39

nmol/l

1.15

582

1849

Codeine or tramadol medication

790

2432

1.79

45.37

1.4

1.3

1.49

1.41

nmol/l

1.05

711

2202

Nonalcoholic fatty liver disease

125

310

4.13

45.27

1.3

1.82

1.43

nmol/l

2.60

104

284

Implicit viral Sepsis

238

878

2.74

45.10

1.3

1.54

1.41

nmol/l

0.85

217

793

All pneumoniae

721

2682

1.80

44.91

1.4

1.3

1.47

1.42

nmol/l

0.65

660

2421

General symptoms and signs

757

2105

1.81

44.48

1.4

1.3

1.47

1.41

nmol/l

0.77

687

1895

Diseases of the digestive system

351

1554

2.27

44.35

1.5

1.3

1.38

1.42

nmol/l

0.25

313

1399

Pneumonia, organism unspecified

657

2509

1.84

44.33

1.4

1.3

1.49

1.41

nmol/l

1.00

598

2261

Dialysis, with operation codes

149

424

3.59

44.29

1.3

1.51

1.41

nmol/l

0.39

125

375

Lower back pain or/and sciatica

747

2753

1.78

44.25

1.3

1.58

1.40

nmol/l

4.00

685

2481

Substance abuse

467

2178

2.03

44.03

1.4

1.3

1.37

1.43

nmol/l

0.48

420

1976

Pneumonias (Asthma/COPD co-morbidities)

713

2679

1.80

43.68

1.4

1.3

1.48

1.42

nmol/l

0.70

652

2419

Dental caries

220

759

2.82

43.61

1.3

1.42

1.40

nmol/l

0.13

196

685

Mental and behavioural disorders due to psychoactive substance use

477

2218

2.01

43.50

1.4

1.3

1.35

1.43

nmol/l

0.74

430

2009

Caries of dentine

201

672

2.94

43.29

1.4

1.2

1.39

1.40

nmol/l

0.04

178

607

Asthma, excluding more controls

553

1463

1.98

43.00

1.4

1.3

1.55

1.35

nmol/l

3.47

508

1322

Pain in throat and chest

602

1916

1.90

42.77

1.4

1.3

1.49

1.37

nmol/l

1.76

547

1736

Abnormalities of breathing

623

1960

1.85

41.13

1.4

1.3

1.55

1.37

nmol/l

3.08

569

1776

Symptoms and signs involving the digestive system and abdomen

695

1931

1.81

41.03

1.4

1.3

1.38

1.42

nmol/l

0.50

632

1743

Asthma

569

1559

1.92

40.76

1.4

1.3

1.54

1.37

nmol/l

2.81

524

1405

Neurological diseases

576

1515

1.92

40.57

1.4

1.3

1.51

1.34

nmol/l

2.77

521

1367

Mental and behavioural disorders due to alcohol, excluding acute intoxication

371

1743

2.14

40.53

1.4

1.3

1.38

1.42

nmol/l

0.26

331

1573

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

267

658

2.58

40.39

1.4

1.48

1.26

nmol/l

2.38

238

597

Abnormal findings on examination of blood, without diagnosis

382

1670

2.12

40.21

1.4

1.3

1.34

1.43

nmol/l

0.82

342

1513

Alcohol use disorder, ICD-based

349

1616

2.18

40.13

1.4

1.3

1.38

1.40

nmol/l

0.12

311

1459

Diseases of pulp and periapical tissues, including avohilmo

690

1997

1.80

40.08

1.4

1.3

1.48

1.40

nmol/l

0.96

623

1809

Malignant neoplasm of pancreas

222

4.54

40.06

1.4

1.2

1.17

1.46

nmol/l

1.69

195

Major coronary heart disease event excluding revascularizations

432

1404

2.06

39.87

1.2

1.3

1.51

1.34

nmol/l

2.44

388

1266

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

689

2684

1.76

39.60

1.4

1.3

1.47

1.42

nmol/l

0.55

628

2423

Episodal and paroxysmal disorders

741

2158

1.75

39.58

1.3

1.58

1.33

nmol/l

6.63

674

1946

Hyperlipidaemia, other/unspecified

291

1151

2.35

39.40

1.3

1.2

1.54

1.40

nmol/l

1.34

261

1040

Other antidepressants

708

2060

1.77

38.89

1.4

1.3

1.48

1.37

nmol/l

1.56

648

1869

Other special examinations and investigations of persons without complaint or reported diagnosis

451

1112

2.06

38.87

1.3

1.47

1.41

nmol/l

0.48

411

1005

Heart failure and coronary heart disease

304

926

2.34

38.77

1.2

1.3

1.64

1.31

nmol/l

4.85

271

837

Mental and behavioural disorders due to alcohol

407

1943

2.03

38.56

1.4

1.3

1.34

1.42

nmol/l

0.76

365

1753

Other diseases of biliary tract

229

4.37

38.42

1.3

1.25

1.52

nmol/l

1.04

204

Asthma (mode)

558

1587

1.89

38.37

1.4

1.3

1.57

1.37

nmol/l

3.51

514

1429

Cholecystectomy

492

2238

1.91

38.36

1.4

1.3

1.50

1.44

nmol/l

0.64

449

2022

Nephropathy related operations

142

431

3.36

38.25

1.4

1.3

1.52

1.46

nmol/l

0.20

120

383

Any mental disorder

744

2154

1.74

38.24

1.4

1.3

1.43

1.41

nmol/l

0.21

675

1939

Complications of procedures, not elsewhere classified

574

2631

1.81

38.04

1.4

1.3

1.48

1.42

nmol/l

0.61

513

2382

Diseases of the skin and subcutaneous tissue

692

1977

1.76

37.48

1.4

1.3

1.46

1.42

nmol/l

0.43

612

1806

Other soft tissue disorders, not elsewhere classified

632

2078

1.79

37.41

1.4

1.3

1.52

1.41

nmol/l

1.53

565

1889

Disorders of lens

503

1649

1.92

37.21

1.3

1.47

1.45

nmol/l

0.18

440

1503

Low back pain

531

2064

1.86

36.87

1.4

1.3

1.60

1.38

nmol/l

3.97

488

1856

Poisoning by medicine

186

674

2.79

36.65

1.4

1.43

nmol/l

0.01

169

609

Poisoning by drugs, medicaments and biological substances

199

747

2.69

36.61

1.4

1.44

nmol/l

0.02

182

668

Dorsalgia

683

2105

1.75

36.35

1.4

1.3

1.53

1.38

nmol/l

2.65

626

1894

Heart failure,strict

376

1284

2.08

35.98

1.2

1.3

1.64

1.33

nmol/l

4.95

335

1174

GASTRO-related operations

521

1380

1.90

35.83

1.4

1.3

1.43

1.39

nmol/l

0.42

474

1264

Any gastric operation

521

1380

1.90

35.83

1.4

1.3

1.43

1.39

nmol/l

0.42

474

1264

Diseases of oesophagus, stomach and duodenum

727

2576

1.69

35.77

1.4

1.3

1.49

1.42

nmol/l

0.82

658

2332

Asthma (only as main-diagnosis), excluding more controls

488

1463

1.92

35.51

1.4

1.3

1.63

1.35

nmol/l

5.79

450

1322

Complications of surgical and medical care, not elsewhere classified

676

2718

1.71

35.39

1.5

1.3

1.48

1.42

nmol/l

0.68

606

2463

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

160

549

2.96

35.02

1.3

1.51

1.47

nmol/l

0.15

149

489

Other and unspecified iron deficiency

250

1067

2.36

34.97

1.4

1.3

1.44

1.46

nmol/l

0.11

223

953

Secondary hypertension

121

5.55

34.86

1.4

1.3

1.66

1.17

nmol/l

2.41

111

Maternal care for other conditions predominantly related to pregnancy

128

378

3.35

34.59

1.6

1.4

1.35

1.48

nmol/l

0.63

115

338

Personality disorders

216

869

2.51

34.50

1.4

1.62

1.44

nmol/l

1.44

202

785

Dyspnoea

612

2622

1.73

34.04

1.4

1.3

1.60

1.40

nmol/l

3.86

559

2364

Nutritional anaemias

340

1600

2.06

33.85

1.4

1.3

1.42

1.43

nmol/l

0.07

307

1440

Amputation of toe

222

4.20

33.83

1.4

1.2

1.19

1.43

nmol/l

1.41

194

Iron deficiency anaemia

298

1368

2.16

33.70

1.4

1.3

1.46

1.45

nmol/l

0.04

268

1227

Asthma, hospital admission 2, infections

401

2043

1.93

33.38

1.4

1.3

1.64

1.38

nmol/l

4.35

373

1838

Asthma-related infections

401

2043

1.93

33.38

1.4

1.3

1.64

1.38

nmol/l

4.35

373

1838

Acute renal failure

185

703

2.66

33.31

1.2

1.55

1.40

nmol/l

0.76

162

622

Hypothyroidism, strict autoimmune

450

1569

1.89

32.79

1.3

1.48

1.52

nmol/l

0.35

393

1450

Certain infectious and parasitic diseases

486

1295

1.89

32.77

1.4

1.3

1.50

1.40

nmol/l

1.04

431

1191

Oxycodone

274

1126

2.22

32.50

1.4

1.3

1.62

1.38

nmol/l

2.46

251

1018

Unstable angina pectoris

262

911

2.29

32.48

1.2

1.3

1.56

1.33

nmol/l

2.55

237

822

ILD medications: prednisolone, methylprednisolone, prednisone

728

2471

1.65

32.33

1.4

1.3

1.57

1.37

nmol/l

4.60

662

2234

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

656

2548

1.68

32.12

1.4

1.3

1.47

1.42

nmol/l

0.56

581

2313

Anxiety disorders, excluding more controls

534

1957

1.78

32.03

1.4

1.3

1.55

1.41

nmol/l

1.84

489

1760

Acidosis

8.77

31.99

1.3

1.2

1.09

1.61

nmol/l

1.62

Myocardial infarction

341

1171

2.06

31.94

1.2

1.3

1.47

1.32

nmol/l

1.76

305

1063

Implicit viral Sepsis

162

588

2.78

31.90

1.3

1.66

1.43

nmol/l

1.41

149

526

Pain in limb

537

2035

1.77

31.80

1.4

1.3

1.50

1.41

nmol/l

1.02

488

1852

Viral Sepsis

162

589

2.78

31.80

1.3

1.66

1.43

nmol/l

1.41

149

527

Alcohol dependence

229

983

2.35

31.78

1.4

1.3

1.43

1.41

nmol/l

0.11

203

880

Volume depletion

241

3.92

31.76

1.4

1.2

1.39

1.42

nmol/l

0.09

212

313

1509

2.07

31.75

1.4

1.3

1.67

1.40

nmol/l

3.65

295

1354

First line medication for Crohn's disease

734

2423

1.64

31.55

1.4

1.3

1.52

1.36

nmol/l

3.50

667

2190

Non-invasive ventilation

10.35

31.52

1.3

1.8

1.55

1.28

nmol/l

0.52

Diarrhoea and gastroenteritis of presumed infectious origin

485

2448

1.79

31.50

1.4

1.3

1.53

1.40

nmol/l

1.53

424

2225

Sciatica+with lumbago

366

1730

1.96

31.36

1.3

1.60

1.38

nmol/l

2.97

341

1543

Asthma (only as main-diagnosis)

491

1559

1.83

31.30

1.4

1.3

1.63

1.37

nmol/l

5.12

453

1405

ILD medications

746

2491

1.63

31.07

1.4

1.3

1.51

1.36

nmol/l

2.87

676

2253

Polyneuropathies and other disorders of the peripheral nervous system

186

734

2.56

31.06

1.4

1.3

1.16

1.46

nmol/l

3.33

160

654

Sleep disorders (combined)

730

2343

1.64

31.03

1.3

1.59

1.34

nmol/l

6.27

672

2106

Disorders of adult personality and behaviour

219

932

2.37

30.97

1.4

1.67

1.44

nmol/l

2.06

203

840

Emotionally unstable personality disorder

107

314

3.45

30.41

1.4

1.5

1.68

1.44

nmol/l

1.14

101

292

Other and unspecified polyneuropathies, also in other diseases

168

640

2.66

30.18

1.4

1.2

1.20

1.50

nmol/l

2.95

147

571

L04AA Selective immunosuppressants

183

729

2.54

29.97

1.4

1.3

1.53

1.45

nmol/l

0.40

161

655

Disorder of lipoprotein metabolism, unspecified

122

393

3.15

29.84

1.2

1.3

1.50

1.42

nmol/l

0.31

108

347

Senile cataract

437

1447

1.86

29.67

1.3

1.45

1.44

nmol/l

0.03

394

1319

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

193

793

2.44

29.23

1.4

1.3

1.39

1.41

nmol/l

0.08

175

712

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

272

1115

2.13

29.23

1.5

1.4

1.64

1.46

nmol/l

1.72

244

1009

Pregnancy hypertension

248

1014

2.20

29.08

1.5

1.4

1.64

1.47

nmol/l

1.48

223

922

Care involving dialysis

257

3.70

29.07

1.3

1.66

1.48

nmol/l

0.57

223

Psychiatric diseases

641

1928

1.67

28.93

1.4

1.3

1.43

1.40

nmol/l

0.24

584

1732

Dental pulpitis, including avohilmo

614

2412

1.66

28.54

1.4

1.3

1.50

1.42

nmol/l

0.98

558

2179

Asthma, unspecified (mode), excluding more controls

351

1357

1.95

28.49

1.3

1.57

1.35

nmol/l

2.57

323

1232

Bacterial infection, other or unspecified

378

1712

1.88

28.19

1.3

1.43

1.39

nmol/l

0.22

339

1553

Specific personality disorders

181

740

2.47

28.05

1.3

1.4

1.64

1.41

nmol/l

1.66

166

666

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

157

4.47

28.05

1.5

1.4

1.70

1.43

nmol/l

1.31

143

Persons encountering health services for examination and investigation

416

1112

1.88

28.00

1.3

1.50

1.41

nmol/l

0.88

375

1005

Other CVD (FINNGEN)

152

4.18

28.00

1.5

1.3

1.30

1.16

nmol/l

0.62

140

Anxiety (asthma-related co-morbidities)

393

1645

1.86

27.93

1.4

1.3

1.54

1.41

nmol/l

1.26

362

1473

Periodontitis

644

2661

1.62

27.79

1.3

1.43

1.44

nmol/l

0.11

578

2407

Symptoms and signs involving the circulatory and respiratory systems

643

1962

1.65

27.56

1.4

1.3

1.53

1.37

nmol/l

2.69

582

1778

Bipolar affective disorders

147

549

2.70

27.47

1.3

1.4

1.72

1.41

nmol/l

2.08

139

491

Arthropathies in other diseases classified elsewhere

102

5.46

27.44

1.3

1.2

1.03

1.50

nmol/l

1.85

Covid-19 confirmed case

263

1269

2.09

27.37

1.3

1.49

1.41

nmol/l

0.51

242

1139

Asthma (diagnoses ohter than nonallergic)

564

2837

1.66

27.25

1.3

1.59

1.40

nmol/l

3.32

524

2556

Other disorders of skin and subcutaneous tissue

454

2315

1.75

27.22

1.4

1.3

1.42

1.44

nmol/l

0.09

394

2103

Dental caries, including avohilmo

452

1281

1.81

27.17

1.3

1.46

1.43

nmol/l

0.16

405

1161

Chronic periodontitis, including avohilmo

640

2665

1.62

27.03

1.3

1.43

1.44

nmol/l

0.07

575

2410

Diseases of pulp and periapical tissues and dental caries

408

1124

1.87

26.93

1.3

1.49

1.41

nmol/l

0.56

365

1022

Pain, not elsewhere classified

198

858

2.32

26.93

1.3

1.60

1.43

nmol/l

1.15

182

769

Other heart diseases, wide

597

2224

1.65

26.77

1.4

1.3

1.57

1.39

nmol/l

2.74

539

2011

Myocardial infarction, strict

309

1109

2.00

26.71

1.2

1.3

1.46

1.33

nmol/l

1.29

277

1008

Intracranial trauma

350

1295

1.91

26.59

1.4

1.3

1.51

1.34

nmol/l

1.88

313

1176

Osteomyelitis

208

3.89

26.53

1.3

1.2

1.40

1.39

nmol/l

0.03

184

Diseases of the eye and adnexa

534

1567

1.71

26.46

1.4

1.3

1.48

1.45

nmol/l

0.23

466

1458

Other cataract

301

1148

2.00

26.39

1.3

1.41

1.44

nmol/l

0.17

256

1049

Medical observation and evaluation for suspected diseases and conditions

403

1112

1.86

26.33

1.5

1.3

1.47

1.41

nmol/l

0.47

366

1005

Amputation of foot

6.58

26.27

1.4

1.2

1.25

1.64

nmol/l

1.03

Spondylopathies

526

1860

1.70

26.20

1.4

1.3

1.54

1.38

nmol/l

2.32

485

1667

Alcoholic liver disease

110

361

3.10

26.19

1.3

1.36

1.44

nmol/l

0.26

100

323

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

134

490

2.76

26.13

1.4

1.29

1.42

nmol/l

0.65

121

439

Oral corticosteroids

690

2599

1.58

26.01

1.4

1.3

1.66

1.37

nmol/l

8.34

630

2347

Peripheral arterial reconstruction

142

538

2.67

25.86

1.4

1.2

1.20

1.47

nmol/l

2.55

124

479

Bacterial infection, other or unspecified

346

1611

1.87

25.86

1.3

1.40

1.38

nmol/l

0.08

309

1457

Hernia of abdominal wall, postoperative

153

602

2.57

25.79

1.5

1.2

1.46

1.38

nmol/l

0.41

134

546

Bleeding

542

2333

1.66

25.74

1.4

1.3

1.48

1.41

nmol/l

0.66

472

2120

Depression or dysthymia

439

1363

1.79

25.64

1.4

1.3

1.39

1.37

nmol/l

0.14

398

1230

Heart failure, strict

395

1548

1.81

25.42

1.2

1.3

1.62

1.37

nmol/l

3.90

351

1409

Persons encountering health services for specific procedures, not carried out

242

3.57

25.42

1.4

1.3

1.32

1.44

nmol/l

0.42

215

Diarrhoea and gastroenteritis of presumed infectious origin

649

2716

1.58

25.02

1.4

1.3

1.51

1.41

nmol/l

1.24

571

2477

Chronic lower respiratory diseases

769

2675

1.54

25.02

1.4

1.3

1.53

1.39

nmol/l

2.46

703

2413

Intestinal infectious diseases

604

2879

1.60

24.98

1.4

1.3

1.51

1.42

nmol/l

1.09

529

2623

Asthma, including avohilmo

751

2749

1.54

24.97

1.3

1.56

1.39

nmol/l

3.46

686

2481

Selective serotonin reuptake inhibitors

634

2066

1.61

24.97

1.3

1.49

1.37

nmol/l

1.59

563

1874

Gout

218

885

2.19

24.97

1.2

1.89

1.32

nmol/l

7.80

205

808

Shoulder lesions

507

1827

1.69

24.91

1.4

1.3

1.48

1.41

nmol/l

0.60

447

1658

Asthma, unspecified (mode)

352

1438

1.85

24.78

1.3

1.57

1.38

nmol/l

2.14

324

1301

Non-selective monoamine reuptake inhibitors

249

1176

2.05

24.74

1.3

1.63

1.38

nmol/l

2.49

226

1059

Mycoses

550

2966

1.62

24.57

1.3

1.50

1.42

nmol/l

0.80

502

2678

Chronic periodontitis, complicated

384

2159

1.77

24.50

1.3

1.35

1.45

nmol/l

1.11

348

1941

Myocardial infarction, without ST-elevation

276

1280

1.98

24.45

1.2

1.3

1.45

1.42

nmol/l

0.22

251

1153

GI-bleeding

222

1053

2.12

24.24

1.3

1.52

1.41

nmol/l

0.59

200

949

Neurotic, stress-related and somatoform disorders

566

2459

1.62

24.23

1.4

1.3

1.52

1.41

nmol/l

1.57

517

2217

Asthma-related pneumonia

238

1157

2.07

24.20

1.3

1.55

1.38

nmol/l

1.47

219

1038

Asthma-related pneumonia or sepsis

238

1157

2.07

24.20

1.3

1.55

1.38

nmol/l

1.47

219

1038

Asthma, hospital admissions 3, pneumonia

238

1157

2.07

24.20

1.3

1.55

1.38

nmol/l

1.47

219

1038

Candidiasis

197

894

2.22

24.08

1.3

1.4

1.57

1.47

nmol/l

0.59

175

801

Cellulitis

168

716

2.37

23.85

1.4

1.3

1.49

1.47

nmol/l

0.06

153

643

Symptoms and signs involving cognition, perception, emotional state and behaviour

623

2708

1.57

23.76

1.3

1.45

1.43

nmol/l

0.16

562

2447

Anxiety disorders

569

2478

1.61

23.72

1.4

1.3

1.54

1.41

nmol/l

1.79

520

2235

All-cause Heart Failure

383

1521

1.79

23.71

1.2

1.3

1.61

1.37

nmol/l

3.54

339

1385

Inflammatory bowel disease treatment related agents

724

2650

1.53

23.66

1.4

1.3

1.60

1.36

nmol/l

6.29

662

2394

Gout, FINNGEN

218

1037

2.11

23.50

1.2

1.3

1.89

1.35

nmol/l

7.08

205

932

Caries of dentine, including avohilmo

466

1392

1.72

23.45

1.3

1.46

1.43

nmol/l

0.22

415

1264

Other diseases of the digestive system

219

1047

2.11

23.45

1.3

1.53

1.42

nmol/l

0.64

198

943

Amputation of ankle bones

6.75

23.17

1.3

1.1

1.52

1.82

nmol/l

0.69

Coronary artery bypass grafting

185

604

2.30

23.16

1.2

1.52

1.28

nmol/l

2.07

168

544

Other reaction to severe stress, and adjustment disorders

242

1207

2.02

23.10

1.5

1.4

1.47

1.44

nmol/l

0.15

220

1083

Polyarthropathies

453

1752

1.70

23.07

1.3

1.63

1.37

nmol/l

4.60

407

1592

Concussion

297

1283

1.90

22.94

1.4

1.3

1.56

1.34

nmol/l

2.37

264

1166

ILD medications: immunosuppressive drugs

415

2271

1.70

22.93

1.4

1.3

1.53

1.37

nmol/l

2.17

369

2052

COPD/asthma related infections

639

2042

1.57

22.79

1.5

1.3

1.47

1.39

nmol/l

1.04

577

1849

COPD/asthma/ILD related infections

639

2042

1.57

22.79

1.5

1.3

1.47

1.39

nmol/l

1.04

577

1849

Intestinal infectious diseases

720

2715

1.52

22.74

1.4

1.3

1.48

1.41

nmol/l

0.87

633

2476

Redundant prepuce, phimosis and paraphimosis

182

812

2.24

22.67

1.4

1.3

1.31

1.37

nmol/l

0.30

164

732

Hyperkalaemia

141

4.27

22.62

1.3

1.2

1.61

1.49

nmol/l

0.28

123

Dialysis

105

4.89

22.55

1.5

1.2

1.49

1.45

nmol/l

0.06

Other and unspecified anaemias

274

1369

1.92

22.45

1.3

1.40

1.42

nmol/l

0.07

251

1234

Paroxysmal tachycardia

119

365

2.74

22.20

1.5

1.4

1.57

1.25

nmol/l

2.03

104

331

Gastrointestinal diseases

350

958

1.84

22.00

1.4

1.3

1.43

1.41

nmol/l

0.07

320

864

Other and unspecified dermatitis

328

1837

1.79

21.96

1.4

1.3

1.53

1.42

nmol/l

1.04

299

1653

Other anaemias

274

1377

1.90

21.90

1.3

1.40

1.42

nmol/l

0.08

251

1241

All anxiety disorders

396

1834

1.71

21.73

1.4

1.3

1.54

1.40

nmol/l

1.56

365

1653

Other medical care

297

1451

1.85

21.60

1.2

1.3

1.50

1.40

nmol/l

0.74

266

1320

Dermatitis

390

2297

1.70

21.55

1.4

1.3

1.57

1.42

nmol/l

1.58

354

2078

Carpal tunnel syndrome

380

1958

1.72

21.47

1.4

1.3

1.63

1.43

nmol/l

2.54

338

1772

Cystitis

511

1887

1.62

21.25

1.4

1.3

1.51

1.43

nmol/l

0.73

458

1705

Diabetic nephropathy, excluding more controls

280

1240

1.90

21.08

1.3

1.44

1.46

nmol/l

0.12

238

1136

Fibrosis and cirrhosis of liver

248

3.29

21.05

1.3

1.74

1.47

nmol/l

1.02

222

Oedema, not elsewhere classified

207

997

2.06

20.97

1.5

1.3

1.49

1.40

nmol/l

0.55

184

893

Other disorders of urethra and urinary system

413

1781

1.68

20.79

1.4

1.3

1.50

1.44

nmol/l

0.52

377

1612

Benzodiazepine use

630

2861

1.52

20.76

1.4

1.3

1.58

1.41

nmol/l

3.02

563

2593

Problems related to lifestyle

286

3.08

20.70

1.4

1.3

1.32

1.42

nmol/l

0.31

257

Disorders of other endocrine glands

277

1477

1.85

20.62

1.3

1.60

1.45

nmol/l

1.37

255

1324

Other dorsopathies, not elsewhere classified

618

2108

1.54

20.38

1.3

1.53

1.38

nmol/l

2.73

570

1897

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

193

937

2.07

19.94

1.4

1.39

1.48

nmol/l

0.55

175

832

Other anxiety disorders

289

1382

1.82

19.91

1.4

1.3

1.51

1.43

nmol/l

0.56

266

1246

Asthma, hospital admissions , main diagnosis only

503

2840

1.57

19.83

1.4

1.3

1.64

1.40

nmol/l

4.63

464

2567

Kela-code for severe mental illness

249

1326

1.89

19.71

1.3

1.4

1.68

1.44

nmol/l

2.53

226

1191

Recurrent or chronic depression

251

922

1.92

19.69

1.5

1.3

1.32

1.37

nmol/l

0.27

225

830

Other gastritis (incl. Duodenitis)

159

721

2.22

19.60

1.3

1.57

1.46

nmol/l

0.57

146

641

Schizophrenia or delusion, excluding more controls

194

941

2.05

19.51

1.3

1.65

1.41

nmol/l

1.92

174

841

Symptoms and signs concerning food and fluid intake

285

3.01

19.51

1.5

1.3

1.25

1.47

nmol/l

1.13

257

Mycoses

184

886

2.09

19.46

1.2

1.3

1.40

1.49

nmol/l

0.47

167

796

Other diseases of intestines

650

2474

1.50

19.33

1.4

1.3

1.52

1.40

nmol/l

1.75

588

2239

Other headache syndromes

246

1313

1.88

19.26

1.4

1.3

1.47

1.36

nmol/l

1.02

224

1168

Aplastic and other anaemias

283

1468

1.81

19.22

1.3

1.42

1.41

nmol/l

0.02

258

1323

Suicide or other Intentional self-harm

168

787

2.15

19.10

1.4

1.36

1.46

nmol/l

0.50

154

699

Other intervertebral disc disorders

515

1983

1.57

19.08

1.4

1.3

1.58

1.38

nmol/l

2.99

472

1779

Substance use, excluding alcohol

143

628

2.30

19.06

1.4

1.3

1.32

1.46

nmol/l

0.81

130

562

Rotator cuff syndrome

390

1688

1.66

18.98

1.4

1.3

1.48

1.42

nmol/l

0.53

342

1528

Gout, idiopatic and unspecified

184

898

2.07

18.82

1.2

1.3

1.97

1.36

nmol/l

7.21

173

805

Unspecified mental disorder

268

1482

1.82

18.82

1.4

1.64

1.44

nmol/l

2.01

243

1335

Other diseases of urinary system

611

2283

1.51

18.74

1.3

1.49

1.42

nmol/l

0.89

550

2068

Soft tissue disorders

613

2093

1.51

18.66

1.4

1.3

1.50

1.40

nmol/l

1.29

547

1904

Pain (limb, back, neck, head abdominally)

438

1343

1.64

18.66

1.3

1.48

1.37

nmol/l

1.08

395

1204

Lumbar disc prolapse

405

1907

1.64

18.65

1.3

1.62

1.39

nmol/l

3.24

369

1707

Hypothyreosis and Thyroxine purchase for inclusion criteria

546

2350

1.53

18.38

1.3

1.48

1.43

nmol/l

0.55

480

2140

Hypothyroidism, strict autoimmune, 3 medication purchases required

490

2122

1.56

18.38

1.3

1.50

1.42

nmol/l

0.82

431

1929

Provisional assignment of new diseases of uncertain etiology

324

1902

1.71

18.37

1.3

1.47

1.43

nmol/l

0.24

300

1707

Codes for special purposes

324

1905

1.71

18.27

1.3

1.47

1.43

nmol/l

0.25

300

1710

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

222

556

2.01

18.24

1.3

1.49

1.40

nmol/l

0.47

198

490

Periapical abscess

301

1739

1.74

18.23

1.4

1.3

1.43

1.42

nmol/l

0.06

274

1561

Oesophageal varices

116

4.24

18.23

1.3

1.2

1.72

1.56

nmol/l

0.34

102

Polycystic ovarian syndrome, consortium definition

362

1269

1.70

18.23

1.4

1.60

1.46

nmol/l

1.49

333

1144

Hypo-osmolality and hyponatraemia

116

471

2.47

18.22

1.3

1.07

1.46

nmol/l

4.50

108

421

Gout, strict definition

145

654

2.24

18.20

1.2

2.05

1.39

nmol/l

6.38

135

583

Complications of medical and surgical care

448

2626

1.57

18.15

1.5

1.3

1.50

1.43

nmol/l

0.71

402

2374

Other functional intestinal disorders

279

1461

1.78

18.10

1.4

1.3

1.53

1.41

nmol/l

0.96

253

1312

Headache

386

1890

1.64

18.00

1.4

1.3

1.64

1.40

nmol/l

3.68

352

1702

Allergic asthma (mode), excluding more controls

146

647

2.22

18.00

1.4

1.3

1.54

1.38

nmol/l

1.07

136

580

Gastroduodenal ulcer

175

851

2.06

17.92

1.4

1.3

1.61

1.42

nmol/l

1.11

158

767

Diseases of oral cavity, salivary glands and jaws

358

1083

1.71

17.85

1.3

1.46

1.41

nmol/l

0.32

322

975

Gestational [pregnancy-induced] hypertension

139

619

2.25

17.83

1.5

1.4

1.70

1.46

nmol/l

1.58

125

558

Hypothyroidism, other/unspecified

530

2292

1.53

17.70

1.3

1.48

1.42

nmol/l

0.54

465

2089

Benign neoplasm of other and ill-defined parts of digestive system

130

567

2.31

17.67

1.4

1.3

1.47

nmol/l

0.01

120

505

Panic disorder

102

399

2.58

17.56

1.4

1.54

1.36

nmol/l

0.77

357

Dermatitis and eczema

669

2860

1.45

17.47

1.4

1.3

1.53

1.41

nmol/l

1.88

607

2587

Factors influencing health status and contact with health services

188

450

2.11

17.43

1.3

1.36

1.46

nmol/l

0.51

172

404

Allergic asthma (mode)

146

656

2.19

17.43

1.4

1.3

1.54

1.41

nmol/l

0.74

136

587

Spondylosis

339

1664

1.67

17.08

1.4

1.3

1.49

1.39

nmol/l

0.82

313

1487

Preparatory care for dialysis

131

3.91

17.05

1.2

1.83

1.42

nmol/l

1.00

118

Other acute lower respiratory infections

323

1843

1.68

17.04

1.4

1.3

1.50

1.41

nmol/l

0.84

298

1656

Chronic ulcer of skin, not elsewhere classified

205

3.22

16.70

1.4

1.3

1.53

1.44

nmol/l

0.24

182

669

2391

1.45

16.61

1.5

1.3

1.52

1.40

nmol/l

1.89

609

2164

Other dialysis

4.44

16.49

1.4

1.2

1.31

1.48

nmol/l

0.38

Disorders of the thyroid gland

561

2470

1.48

16.41

1.3

1.48

1.42

nmol/l

0.61

492

2251

Pruritus

288

2.81

16.27

1.4

1.61

1.43

nmol/l

0.67

262

Bronchitis

632

2764

1.44

16.02

1.4

1.3

1.52

1.40

nmol/l

1.83

576

2499

Symptoms and signs involving the nervous and musculoskeletal systems

350

2179

1.61

15.95

1.4

1.3

1.58

1.41

nmol/l

2.24

313

1967

Genitourinary diseases

376

1158

1.63

15.92

1.3

1.48

1.32

nmol/l

1.74

339

1053

Irregular menses

245

1084

1.79

15.91

1.5

1.4

1.65

1.45

nmol/l

1.94

229

980

Excluding asthma or asthma-COPD overlap

484

1583

1.54

15.85

1.4

1.3

1.48

1.37

nmol/l

1.38

433

1426

Erythema intertrigo

5.61

15.80

1.3

1.2

1.90

1.34

nmol/l

1.40

Use of hypnotics and sedatives

656

2634

1.43

15.75

1.3

1.46

1.43

nmol/l

0.35

586

2386

Dorsopathies

606

2112

1.46

15.73

1.4

1.3

1.55

1.37

nmol/l

3.18

560

1901

Alcohol abuse, main dg, excluding more controls

111

481

2.33

15.38

1.4

1.3

1.16

1.44

nmol/l

2.31

105

425

Gingivitis and periodontal diseases

603

2145

1.45

15.30

1.3

1.41

1.43

nmol/l

0.17

535

1950

All influenza

163

824

1.99

15.20

1.3

1.55

1.41

nmol/l

0.95

151

734

Extracorporeal dialysis

189

3.18

14.84

1.3

1.56

1.39

nmol/l

0.40

168

Other pulmonary diagnosis

478

1583

1.52

14.83

1.4

1.3

1.48

1.37

nmol/l

1.24

427

1426

Late syphilis

5.60

14.61

1.5

1.3

0.87

1.53

nmol/l

2.49

Diabetic retinopathy, excluding more controls

440

1625

1.54

14.52

1.3

1.15

1.48

nmol/l

8.86

361

1485

Necrosis of pulp, including avohilmo

357

2283

1.57

14.43

1.4

1.3

1.51

1.42

nmol/l

0.79

326

2061

Hernia of abdominal wall

294

1801

1.64

14.43

1.4

1.3

1.53

1.41

nmol/l

0.94

265

1625

Exclusions for E4_PCOS_BROAD

117

534

2.21

14.33

1.3

1.63

1.44

nmol/l

0.99

108

483

Spinal stenosis

309

1442

1.63

14.31

1.3

1.63

1.39

nmol/l

2.66

283

1295

Adenocarcinoma and ductal carcinoma of pancreas

102

4.02

14.21

1.2

1.09

1.40

nmol/l

0.92

Disease of hard tissues of teeth, NOS

330

1061

1.63

14.16

1.4

1.3

1.47

1.42

nmol/l

0.33

302

953

Explicit bacterial Sepsis

310

2.61

14.16

1.2

1.3

1.47

1.48

nmol/l

0.05

278

Acute sinusitis

305

1751

1.62

14.07

1.5

1.3

1.48

1.43

nmol/l

0.32

273

1569

Acute bronchitis

237

1353

1.72

14.04

1.4

1.3

1.50

1.42

nmol/l

0.53

220

1214

Presence of other functional implants

344

1507

1.59

14.02

1.4

1.3

1.38

1.40

nmol/l

0.11

300

1361

Implicit fungal Sepsis

180

3.15

14.00

1.2

1.3

1.76

1.54

nmol/l

0.56

162

Acute upper respiratory infections of multiple and unspecified sites

432

2136

1.50

13.91

1.4

1.3

1.54

1.41

nmol/l

1.48

389

1927

Fracture of lower leg, including ankle

329

2068

1.58

13.88

1.4

1.3

1.43

nmol/l

0.01

292

1869

COPD differential diagnosis

473

1587

1.50

13.85

1.4

1.3

1.48

1.37

nmol/l

1.31

423

1429

ILD differential diagnosis

473

1587

1.50

13.84

1.4

1.3

1.48

1.37

nmol/l

1.31

423

1429

Missing teeth due to accident, extraction or parodontitis

359

2189

1.55

13.84

1.3

1.43

1.44

nmol/l

0.09

316

1981

Acute upper respiratory infections

597

2598

1.42

13.83

1.5

1.3

1.52

1.42

nmol/l

1.25

541

2350

Trigger finger

100

435

2.32

13.79

1.3

1.45

1.53

nmol/l

0.28

391

Autoimmune diseases related-to ILD

498

2943

1.45

13.75

1.4

1.3

1.53

1.42

nmol/l

1.43

449

2665

Streptococcal septicaemia

258

2.75

13.70

1.1

1.2

1.50

1.51

nmol/l

0.03

226

Benign neoplasm of colon, rectum, anus and anal canal

378

2151

1.53

13.61

1.4

1.3

1.53

1.42

nmol/l

1.07

347

1935

Persistent mood disorders

118

556

2.14

13.39

1.4

1.3

1.60

1.44

nmol/l

0.81

106

495

Gout, unspecified

144

731

1.99

13.38

1.1

1.2

2.01

1.38

nmol/l

6.06

134

652

Injuries to the ankle and foot

413

2463

1.49

13.34

1.4

1.3

1.54

1.41

nmol/l

1.55

373

2228

Maternal care for other known or suspected fetal problems

119

343

2.21

13.32

1.6

1.4

1.66

1.47

nmol/l

0.85

108

307

Vitreous haemorrhage

336

2.47

12.98

1.4

1.3

1.23

1.47

nmol/l

1.16

302

Injuries to the knee and lower leg

688

2786

1.37

12.96

1.3

1.44

1.43

nmol/l

0.04

621

2522

Other metabolic disorders

318

2.50

12.95

1.3

1.4

1.31

1.47

nmol/l

0.68

283

Pre-eclampsia or eclampsia

117

557

2.11

12.94

1.4

1.60

1.46

nmol/l

0.68

108

507

Constipation

515

2493

1.43

12.92

1.3

1.55

1.41

nmol/l

1.85

469

2249

Fall on same level

673

2674

1.38

12.85

1.4

1.3

1.44

1.43

nmol/l

0.05

614

2415

Open wound of ankle and foot

320

2.49

12.81

1.4

1.3

1.39

1.45

nmol/l

0.20

288

Schizophrenia or delusion

194

1099

1.77

12.78

1.3

1.4

1.65

1.46

nmol/l

1.42

174

984

Asthma/COPD (KELA code 203)

549

2669

1.41

12.75

1.3

1.58

1.39

nmol/l

3.28

502

2407

Dermatophytosis

366

2429

1.51

12.66

1.3

1.48

1.42

nmol/l

0.41

339

2186

341

2.42

12.55

1.7

1.3

1.33

1.46

nmol/l

0.57

308

Schizophrenia, schizotypal and delusional disorders

194

1106

1.76

12.52

1.3

1.4

1.65

1.45

nmol/l

1.45

174

991

Heart failure and bmi 25plus

218

851

1.74

12.52

1.2

1.63

1.43

nmol/l

1.69

196

768

Pre-eclampsia or poor fetal growth

153

810

1.89

12.41

1.5

1.4

1.57

1.49

nmol/l

0.40

140

727

Presence of cardiac and vascular implants and grafts

271

1246

1.62

12.28

1.3

1.61

1.38

nmol/l

2.55

251

1130

Ascites

211

2.83

12.27

1.2

1.47

1.52

nmol/l

0.12

192

Other and unspecified local infections of skin and subcutaneous tissue

291

2.54

12.26

1.4

1.3

1.30

1.49

nmol/l

0.79

260

Other/unspecified dorsalgia

214

1251

1.70

12.22

1.4

1.3

1.55

1.38

nmol/l

1.40

191

1106

Dizziness and giddiness

425

2310

1.46

12.15

1.3

1.46

1.44

nmol/l

0.14

393

2091

Injuries to the head

640

2879

1.37

12.12

1.4

1.3

1.39

1.44

nmol/l

0.47

584

2603

Diabetic nephropathy

281

1765

1.60

12.11

1.3

1.43

1.41

nmol/l

0.12

239

1607

Chronic gastritis

156

845

1.86

11.95

1.3

1.42

1.43

nmol/l

0.05

140

759

Diabetic maculopathy

249

1454

1.65

11.95

1.3

1.00

1.48

nmol/l

14.67

194

1332

Pain in joint

318

1303

1.56

11.93

1.4

1.3

1.49

1.38

nmol/l

0.99

288

1165

Superficial injury of head

142

750

1.90

11.77

1.4

1.3

1.31

1.42

nmol/l

0.63

128

669

Phobic anxiety disorders

339

2.37

11.73

1.2

1.4

1.64

1.34

nmol/l

1.18

309

Status post-ami

150

608

1.89

11.61

1.2

1.3

1.70

1.30

nmol/l

3.53

133

547

Other and unspecified effects of external causes

163

904

1.81

11.59

1.6

1.4

1.67

1.44

nmol/l

1.52

145

805

Dental operations

358

1210

1.52

11.57

1.3

1.51

1.43

nmol/l

0.59

321

1096

Benign neoplasm: Colon

314

1972

1.53

11.38

1.4

1.3

1.54

1.41

nmol/l

1.31

289

1780

Other local infections of skin and subcutaneous tissue

315

2.40

11.30

1.4

1.3

1.28

1.49

nmol/l

0.89

281

Amenorrhoea

140

3.17

11.23

1.5

1.4

1.65

1.42

nmol/l

0.65

124

Cholangitis (primary sclerosing, PSC)

161

3.02

11.23

1.6

1.3

1.18

1.46

nmol/l

0.86

141

Candidiasis

397

2.23

11.23

1.2

1.4

1.43

1.49

nmol/l

0.20

361

Osteopathies and chondropathies

311

1907

1.52

11.19

1.5

1.3

1.50

1.41

nmol/l

0.65

278

1714

Diabetic neuropathy

201

1197

1.70

11.16

1.4

1.3

1.20

1.42

nmol/l

2.61

180

1071

Pre-eclampsia

105

509

2.07

11.14

1.4

1.64

1.48

nmol/l

0.80

462

Alcohol abuse, main dg

111

550

2.03

11.13

1.4

1.3

1.16

1.46

nmol/l

2.55

105

496

Other symptoms and signs involving the nervous and musculoskeletal systems

239

1489

1.61

11.08

1.5

1.3

1.65

1.41

nmol/l

2.65

208

1344

Finngen Rheumatological endpoints

553

2284

1.38

10.89

1.4

1.3

1.59

1.34

nmol/l

5.35

498

2064

Psoriasis

179

1040

1.73

10.89

1.3

1.62

1.45

nmol/l

1.28

163

933

Other neurological diseases

405

2213

1.44

10.83

1.3

1.40

1.43

nmol/l

0.21

354

2007

Other follicular disorders

204

2.73

10.73

1.3

1.4

1.80

1.48

nmol/l

1.36

187

Adverse effects, not elsewhere classified

115

585

1.98

10.71

1.6

1.3

1.74

1.45

nmol/l

1.77

102

528

Injuries to the thorax

265

1708

1.56

10.63

1.4

1.3

1.22

1.41

nmol/l

2.78

241

1539

Disorders of skin appendages

270

1748

1.55

10.58

1.4

1.3

1.56

1.43

nmol/l

1.05

234

1581

Acute peritonitis

184

2.81

10.50

1.4

1.3

1.39

1.46

nmol/l

0.17

163

Sequelae of external causes of morbidity and mortality

155

876

1.78

10.41

1.6

1.3

1.49

1.48

nmol/l

0.06

142

781

Other and unspecified nonorganic psychotic disorders

117

606

1.94

10.36

1.3

1.4

1.61

1.41

nmol/l

1.03

103

552

Sequelae with surgical and medical care as external cause

126

670

1.89

10.32

1.5

1.3

1.49

1.50

nmol/l

0.03

117

599

Care involving use of rehabilitation procedures

354

2241

1.46

10.24

1.3

1.46

1.42

nmol/l

0.30

309

2040

Acute pharyngitis

429

2.12

10.20

1.3

1.22

1.41

nmol/l

1.07

389

Acute alcohol intoxication

157

897

1.76

10.17

1.4

1.3

1.19

1.44

nmol/l

2.43

149

797

Schizoaffective disorder

222

2.60

10.12

1.2

1.4

1.44

1.41

nmol/l

0.09

204

Disorders of sclera, cornea, iris and ciliary body

311

2102

1.48

10.03

1.4

1.3

1.45

1.41

nmol/l

0.22

276

1897

Other symptoms and signs involving cognitive functions and awareness

249

1459

1.56

9.98

1.4

1.3

1.43

1.42

nmol/l

0.05

218

1319

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

341

2318

1.46

9.96

1.5

1.3

1.52

1.42

nmol/l

0.81

310

2090

Abnormalities of heart beat

186

1099

1.67

9.88

1.5

1.3

1.53

1.38

nmol/l

1.02

163

989

Urolithiasis

192

1169

1.65

9.85

1.2

1.3

1.62

1.41

nmol/l

1.77

176

1052

Papulosquamous disorders

229

1458

1.58

9.78

1.2

1.3

1.57

1.43

nmol/l

1.23

206

1313

Postprocedural endocrine and metabolic disorders, not elsewhere classified

299

2.32

9.73

1.3

1.4

1.33

1.51

nmol/l

0.69

265

Diseases of the musculoskeletal system and connective tissue

299

987

1.52

9.69

1.3

1.46

1.35

nmol/l

0.84

264

902

Other postsurgical states

187

2.70

9.64

2.3

1.2

1.59

1.47

nmol/l

0.28

165

Otitis externa

130

716

1.83

9.56

1.5

1.3

1.49

1.47

nmol/l

0.06

113

641

Injury, poisoning and certain other consequences of external causes

299

991

1.52

9.51

1.4

1.3

1.53

1.41

nmol/l

0.93

272

902

Cholecystitis

386

2.14

9.48

1.2

1.3

1.44

1.46

nmol/l

0.06

342

Calculus of kidney and ureter

178

1075

1.66

9.45

1.2

1.3

1.63

1.40

nmol/l

1.91

163

963

Falls/tendency to fall

624

2361

1.33

9.35

1.4

1.3

1.41

1.44

nmol/l

0.23

570

2131

Adenocarcinoma of pancreas

3.76

9.20

1.1

1.2

1.02

1.42

nmol/l

1.00

Early onset COPD, excluding more controls

129

718

1.81

9.17

1.6

1.2

1.53

1.38

nmol/l

0.72

121

659

Benign neoplasms

557

2296

1.34

9.15

1.4

1.3

1.48

1.40

nmol/l

0.83

504

2070

Diseases of the respiratory system

356

1234

1.45

9.09

1.4

1.3

1.48

1.37

nmol/l

0.97

319

1114

Fracture of rib(s), sternum and thoracic spine

176

1072

1.65

9.06

1.4

1.3

1.17

1.43

nmol/l

3.51

159

963

Hypokalaemia

328

2.21

9.06

1.4

1.3

1.54

1.47

nmol/l

0.18

292

Unspecified acute lower respiratory infection

488

1.98

9.05

1.4

1.3

1.49

1.46

nmol/l

0.10

435

Other diseases of hard tissues of teeth

310

1082

1.49

9.05

1.3

1.43

1.41

nmol/l

0.11

280

974

AV-block

105

479

1.93

9.02

1.4

1.3

1.24

1.38

nmol/l

0.68

426

Diverticular disease of intestine

407

1862

1.40

8.99

1.3

1.59

1.40

nmol/l

2.49

368

1680

Convulsions, not elsewhere classified

130

721

1.79

8.96

1.5

1.3

1.20

1.39

nmol/l

1.18

118

644

Prurigo nodularis

3.99

8.91

1.2

1.4

1.58

1.32

nmol/l

0.52

Radiculopathy

491

1.97

8.89

1.3

1.57

1.44

nmol/l

0.42

430

Cervicobrachial syndrome

127

712

1.79

8.85

1.3

1.56

1.43

nmol/l

0.56

122

630

Other obstetric conditions, not elsewhere classified

138

493

1.79

8.78

1.6

1.5

1.53

1.51

nmol/l

0.09

127

444

Psoriasis vulgaris

119

658

1.82

8.70

1.3

1.69

1.46

nmol/l

1.46

107

588

Malignant neoplasm of digestive organs

230

1181

1.54

8.68

1.3

1.33

1.43

nmol/l

0.59

206

1069

Injuries to the abdomen, lower back, lumbar spine and pelvis

211

1344

1.56

8.62

1.6

1.3

1.24

1.43

nmol/l

1.91

191

1202

Diseases of external ear

188

1183

1.60

8.51

1.4

1.3

1.46

1.43

nmol/l

0.16

166

1058

Decubitus ulcer and pressure area

166

2.68

8.39

1.3

1.2

1.52

1.42

nmol/l

0.22

146

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

132

472

1.78

8.35

1.5

1.55

1.51

nmol/l

0.15

121

423

Other diseases of lip and oral mucosa

218

1427

1.53

8.31

1.5

1.3

1.43

1.45

nmol/l

0.08

197

1280

Umbilical hernia

174

1082

1.62

8.30

1.4

1.3

1.51

1.44

nmol/l

0.35

158

987

Asthma and allergy, excluding more controls

316

2.17

8.30

1.3

1.46

1.29

nmol/l

0.64

283

Asthma and allergy

316

2.17

8.30

1.3

1.46

1.33

nmol/l

0.45

282

Anosmia

+∞

8.25

1.0

0.0

1.41

—

nmol/l

—

Urticaria and erythema

194

1242

1.57

8.17

1.5

1.3

1.58

1.44

nmol/l

0.86

177

1115

Migraine

233

1251

1.51

8.15

1.5

1.4

1.59

1.35

nmol/l

2.72

216

1125

Other noninfective gastroenteritis and colitis

132

767

1.73

8.14

1.4

1.3

1.55

1.46

nmol/l

0.33

122

684

Cardiomyopathies, Primary/intrinsic

404

2.02

8.11

1.2

1.3

1.84

1.35

nmol/l

2.69

364

Other infective otitis externa

175

2.60

8.10

1.3

1.54

1.43

nmol/l

0.24

159

Diseases of peritoneum

305

2.18

8.08

1.4

1.3

1.42

1.51

nmol/l

0.31

274

Persons encountering health services in other circumstances

196

1255

1.56

8.06

1.6

1.3

1.48

1.43

nmol/l

0.30

182

1134

Familial hypercholesterolemia

447

1.96

8.01

1.3

1.2

1.55

1.40

nmol/l

0.70

396

Schizophrenia

101

546

1.86

7.98

1.2

1.3

1.68

1.42

nmol/l

1.29

488

Gastric ulcer

102

553

1.85

7.98

1.4

1.2

1.61

1.48

nmol/l

0.49

489

Speech and linguistic disorders, excluding more controls

138

2.74

7.94

1.4

1.2

1.63

1.36

nmol/l

0.75

126

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

459

1.89

7.89

1.5

1.4

1.70

1.35

nmol/l

1.93

424

Dysphagia

127

738

1.73

7.87

1.6

1.2

1.36

1.41

nmol/l

0.22

112

654

Cardiomyopathy

104

570

1.83

7.87

1.3

1.74

1.37

nmol/l

2.32

517

Nonorganic sleeping disorders, excluding more controls

527

1.87

7.86

1.3

1.44

nmol/l

0.01

471

Migraine with aura

113

635

1.79

7.85

1.5

1.4

1.60

1.39

nmol/l

1.25

104

566

Other disorders of skin and subcutaneous tissue, not elsewhere classified

437

1.96

7.82

1.4

1.3

1.48

1.50

nmol/l

0.07

395

Myalgia

126

733

1.73

7.78

1.2

1.3

1.56

1.44

nmol/l

0.47

106

664

Viral infections characterized by skin and mucous membrane lesions

465

3002

1.33

7.76

1.3

1.51

1.43

nmol/l

0.88

417

2718

Excessive, frequent and irregular menstruation

183

626

1.61

7.73

1.5

1.4

1.69

1.40

nmol/l

2.73

158

563

Syphilis

3.32

7.70

1.4

1.2

0.94

1.42

nmol/l

1.78

Syphilis

3.32

7.70

1.4

1.2

0.94

1.42

nmol/l

1.78

Certain disorders involving the immune mechanism

114

647

1.77

7.70

1.2

1.3

1.61

1.46

nmol/l

0.65

104

580

Isolated proteinuria

3.39

7.69

1.8

1.2

1.81

1.43

nmol/l

0.93

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

308

2188

1.41

7.69

1.6

1.3

1.53

1.42

nmol/l

0.89

278

1972

Cardiomyopathy (excluding other)

420

1.97

7.64

1.2

1.3

1.82

1.37

nmol/l

2.41

379

Social phobias

192

2.46

7.64

1.3

1.4

1.47

1.36

nmol/l

0.25

178

Hernia

516

2647

1.31

7.57

1.4

1.3

1.42

1.44

nmol/l

0.19

462

2397

Glaucoma suspect

187

1211

1.55

7.54

1.3

1.47

1.42

nmol/l

0.23

167

1089

Cervical disc disorders

202

1332

1.52

7.50

1.4

1.3

1.65

1.39

nmol/l

2.12

179

1188

Open wound of lower leg

486

1.88

7.49

1.3

1.36

1.42

nmol/l

0.20

442

Unspecified jaundice

130

2.80

7.49

1.3

1.2

1.25

1.53

nmol/l

0.82

116

Arthropathies

500

1921

1.32

7.46

1.3

1.53

1.37

nmol/l

2.24

441

1751

Gonarthrosis [arthrosis of knee](FG)

428

1852

1.35

7.45

1.4

1.3

1.61

1.34

nmol/l

5.04

393

1670

Duodenal ulcer

342

2.06

7.45

1.3

1.2

1.49

1.46

nmol/l

0.05

300

Excessive earwax

294

2037

1.41

7.41

1.3

1.50

1.42

nmol/l

0.69

261

1843

Other keratitis

336

2.07

7.41

1.5

1.3

1.48

1.42

nmol/l

0.16

307

External causes of morbidity and mortality

361

1305

1.39

7.41

1.4

1.3

1.50

1.40

nmol/l

0.79

327

1188

Syncope and collapse

229

1326

1.48

7.35

1.4

1.3

1.39

1.43

nmol/l

0.25

209

1192

Pacemaker

165

1000

1.59

7.34

1.4

1.2

1.50

1.41

nmol/l

0.42

145

906

Visual disturbances and blindness

269

1885

1.43

7.32

1.4

1.3

1.43

nmol/l

0.00

242

1697

Other external causes of accidental injury

460

1731

1.33

7.31

1.5

1.3

1.47

1.43

nmol/l

0.28

410

1565

Vasomotor and allergic rhinitis

204

1330

1.51

7.30

1.3

1.61

1.44

nmol/l

1.19

182

1200

Rheumatism, unspecified

345

2.04

7.28

1.4

1.3

1.95

1.47

nmol/l

1.95

312

Non-allergic asthma (mode), excluding more controls

545

1.81

7.17

1.4

1.2

1.53

1.32

nmol/l

1.42

491

Mental and behavioural disorders due to sedatives or hypnotics

211

2.34

7.14

1.4

1.20

1.45

nmol/l

0.92

193

Gonarthrosis

368

1535

1.37

7.11

1.4

1.3

1.60

1.37

nmol/l

3.38

338

1394

Non-allergic asthma (mode)

547

1.80

7.09

1.4

1.2

1.53

1.39

nmol/l

0.81

492

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

193

2.40

7.09

1.6

1.4

1.60

1.39

nmol/l

0.66

175

Glaucoma

285

1742

1.41

7.07

1.3

1.41

1.44

nmol/l

0.17

257

1573

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

107

2.94

7.03

1.6

1.4

0.99

1.55

nmol/l

2.35

100

Cervicalgia

111

643

1.73

7.01

1.4

1.3

1.41

1.44

nmol/l

0.10

105

566

Accidents

457

1731

1.32

6.98

1.4

1.3

1.48

1.43

nmol/l

0.38

407

1565

Use of disulfiram, acamprosate or naltrexone

331

2.04

6.97

1.3

1.50

1.45

nmol/l

0.13

302

Misadventures to patients during surgical and medical care

463

1.87

6.95

1.3

1.49

1.47

nmol/l

0.06

416

Lesion of ulnar nerve

457

1.87

6.90

1.2

1.3

1.51

1.45

nmol/l

0.17

415

Fracture of foot, except ankle

129

782

1.66

6.90

1.3

1.41

1.43

nmol/l

0.10

115

706

Cough

202

1282

1.49

6.89

1.3

1.42

1.38

nmol/l

0.19

182

1162

Visual impairment including blindness (binocular or monocular)

190

2.39

6.86

1.4

1.3

1.24

1.45

nmol/l

0.66

169

Intracranial injury

312

2147

1.38

6.82

1.4

1.3

1.49

1.42

nmol/l

0.50

281

1940

Diseases of the ear and mastoid process

646

2578

1.26

6.74

1.3

1.48

1.42

nmol/l

0.62

580

2345

Behavioural syndromes associated with physiological disturbances and physical factors

490

2689

1.29

6.74

1.4

1.3

1.50

1.42

nmol/l

0.89

455

2423

Other complications of surgical and medical care, not elsewhere classified

288

2.10

6.74

1.5

1.2

1.33

1.44

nmol/l

0.32

266

Noninfective enteritis and colitis

247

1731

1.43

6.73

1.4

1.3

1.47

1.42

nmol/l

0.35

224

1557

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

275

2.13

6.72

1.6

1.3

1.56

1.47

nmol/l

0.19

249

Familial hypercholesterolemia, with ischemic heart disease

243

2.20

6.68

1.2

1.65

1.43

nmol/l

0.78

216

Follow-up examination after treatment for conditions other than malignant neoplasms

204

903

1.50

6.68

1.3

1.37

1.40

nmol/l

0.15

177

817

Viral and other specified intestinal infections

132

784

1.63

6.61

1.4

1.59

1.41

nmol/l

0.88

120

722

Personal history of other diseases and conditions

256

2.15

6.59

1.1

1.3

1.39

1.42

nmol/l

0.08

232

Keratitis

191

1282

1.49

6.58

1.5

1.3

1.47

1.46

nmol/l

0.04

167

1147

Dermatophytosis

458

1.85

6.55

1.2

1.3

1.44

1.49

nmol/l

0.18

408

Other specific joint derangements/joint disorders

389

1889

1.33

6.54

1.4

1.3

1.48

1.38

nmol/l

1.01

351

1719

Corns and callosities

201

2.31

6.52

1.3

1.50

1.42

nmol/l

0.16

178

Superficial injury of ankle and foot

320

2.01

6.45

1.3

1.47

1.45

nmol/l

0.04

286

Cerebrovascular diseases

396

2106

1.32

6.44

1.3

1.46

1.43

nmol/l

0.16

352

1911

Viral infections characterized by skin and mucous membrane lesions

225

1565

1.44

6.43

1.3

1.55

1.41

nmol/l

1.32

204

1399

Bell's palsy

363

1.94

6.37

1.3

1.42

1.46

nmol/l

0.15

325

Tubulo-interstitial nephritis, not specified as acute or chronic

166

2.43

6.35

1.1

1.3

1.55

1.51

nmol/l

0.10

144

Urticaria

152

980

1.56

6.33

1.6

1.4

1.53

1.46

nmol/l

0.32

137

873

Allergic rhinitis

153

977

1.55

6.31

1.3

1.4

1.66

1.41

nmol/l

1.60

138

881

Non-ischemic cardiomyopathy

141

715

1.59

6.28

1.2

1.3

1.53

1.36

nmol/l

1.10

125

647

Gonarthrosis,primary

486

2333

1.29

6.24

1.4

1.3

1.64

1.40

nmol/l

4.39

444

2101

Vascular diseases of the intestine

3.02

6.23

1.6

1.1

1.46

1.52

nmol/l

0.12

Tobacco use

168

2.41

6.22

1.3

1.4

1.40

1.47

nmol/l

0.13

154

Other problems related to primary support group, including family circumstances

269

2.07

6.21

1.3

1.4

1.63

1.42

nmol/l

0.60

247

Exclusions for E4_PCOS_CONSORTIUM

339

1578

1.35

6.14

1.5

1.3

1.60

1.43

nmol/l

1.67

303

1427

Drug-induced adrenocortical insufficiency

3.83

6.12

1.4

1.1

2.08

1.45

nmol/l

0.97

Conduction disorders

153

802

1.55

6.12

1.3

1.34

1.38

nmol/l

0.22

134

733

Ventral hernia

132

832

1.59

6.09

1.3

1.55

1.45

nmol/l

0.41

118

744

Corneal ulcer

102

604

1.70

6.03

1.5

1.3

1.26

1.45

nmol/l

0.95

539

Injuries to the shoulder and upper arm

448

2812

1.29

6.02

1.4

1.3

1.45

1.43

nmol/l

0.20

407

2538

Hyperkinetic disorders, excluding more controls

217

2.17

6.01

1.6

1.5

1.85

1.28

nmol/l

2.22

198

Inflammatory diseases of female pelvic organs

259

1366

1.40

6.00

1.4

1.58

1.47

nmol/l

0.83

233

1238

Trochanteric bursitis

378

1.89

5.99

1.2

1.3

1.66

1.48

nmol/l

0.61

346

Noninfectious colitis NAS

400

1.86

5.96

1.5

1.3

1.48

1.45

nmol/l

0.09

363

Bacterial pneumoniae

206

1259

1.45

5.95

1.3

1.40

1.38

nmol/l

0.11

192

1136

Degeneration of macula and posterior pole

216

1199

1.44

5.95

1.2

1.3

1.32

1.49

nmol/l

1.47

188

1099

Infections of genitourinary tract in pregnancy

184

2.30

5.93

1.4

1.5

1.69

1.41

nmol/l

1.09

167

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

210

2.21

5.91

1.4

1.30

1.39

nmol/l

0.27

191

Unspecified privation

331

1.95

5.90

1.3

1.45

1.47

nmol/l

0.04

296

Other inflammatory liver diseases

191

2.27

5.90

1.8

1.3

1.18

1.38

nmol/l

0.74

169

Early onset COPD

129

817

1.59

5.86

1.6

1.3

1.53

1.43

nmol/l

0.43

121

732

All influenza (not pneumonia)

475

1.78

5.85

1.4

1.2

1.51

1.42

nmol/l

0.30

426

Generalized anxiety disorder

410

1.84

5.83

1.3

1.4

1.66

1.39

nmol/l

0.86

369

Disorders of synovium and tendon

268

1713

1.37

5.78

1.4

1.3

1.51

1.42

nmol/l

0.67

239

1551

Other CVD

102

612

1.67

5.75

1.4

1.2

1.29

1.48

nmol/l

1.09

546

Other and unspecified tonsillitis

178

1016

1.48

5.71

1.4

1.3

1.52

1.40

nmol/l

0.79

165

913

Retention of urine

192

1086

1.46

5.70

1.4

1.3

1.40

1.42

nmol/l

0.08

165

989

Abscess of anal and rectal regions

294

1.99

5.69

1.3

1.53

1.42

nmol/l

0.30

266

124

681

1.59

5.62

1.2

1.35

1.51

nmol/l

0.84

114

621

Alcohol withdrawal state with delirium

248

2.08

5.61

1.3

1.30

1.41

nmol/l

0.31

225

Visual disturbances

243

1760

1.38

5.61

1.4

1.3

1.47

1.42

nmol/l

0.29

219

1586

Disorders of vitreous body and globe

259

1819

1.37

5.60

1.4

1.3

1.57

1.42

nmol/l

1.28

223

1640

Bacterial pneumonia (organism specified)

221

1426

1.41

5.59

1.3

1.39

1.38

nmol/l

0.04

207

1280

Vascular disorders of the intestines

196

2.21

5.56

1.5

1.2

1.44

1.48

nmol/l

0.10

173

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

170

1157

1.47

5.55

1.3

1.56

1.45

nmol/l

0.62

152

1038

Arthrosis

393

1658

1.30

5.55

1.4

1.3

1.60

1.37

nmol/l

3.52

353

1506

Exposure to unspecified factor

525

3027

1.25

5.54

1.4

1.3

1.39

1.44

nmol/l

0.40

469

2747

Other degenerative diseases of the nervous system

124

583

1.59

5.53

1.2

1.3

1.19

1.41

nmol/l

2.03

110

527

Invasive ventilation

217

2.14

5.48

1.7

1.3

1.01

1.42

nmol/l

2.34

195

Use of pramipexole

114

714

1.60

5.46

1.4

1.3

1.63

1.47

nmol/l

0.66

100

633

Migraine without aura

471

1.75

5.44

1.4

1.51

1.36

nmol/l

0.58

418

Zoster [herpes zoster]

241

1728

1.38

5.38

1.3

1.54

1.42

nmol/l

1.05

219

1553

Wet age-related macular degeneration

395

1.80

5.33

1.3

1.2

1.22

1.49

nmol/l

1.95

350

Other and unspecified drugs and medicaments

268

1.99

5.26

1.6

1.3

1.61

1.48

nmol/l

0.28

240

Transport accidents

246

1549

1.37

5.24

1.3

1.37

1.43

nmol/l

0.42

223

1396

Paracetamol or NSAID medication

238

1.78

5.23

1.3

1.48

1.26

nmol/l

0.88

217

Abnormalities of gait and mobility

389

1.81

5.23

1.3

1.48

1.51

nmol/l

0.07

349

Delirium, not induced by alcohol and other psychoactive substances

346

1.86

5.18

1.2

1.3

1.39

1.50

nmol/l

0.21

304

Vitamin B12 deficiency anaemia

305

1.91

5.14

1.5

1.3

1.19

1.46

nmol/l

0.94

274

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

128

826

1.54

5.12

1.4

1.37

1.47

nmol/l

0.43

110

739

Undetermined asthma, excluding more controls

355

1.84

5.12

1.4

1.3

1.61

1.41

nmol/l

0.57

321

Gastro-oesophageal reflux disease

342

2275

1.30

5.12

1.3

1.49

1.42

nmol/l

0.55

311

2054

Soft tissue disorders related to use, overuse and pressure

137

909

1.51

5.11

1.3

1.2

1.55

1.44

nmol/l

0.51

128

824

Haemorrhage from respiratory passages

170

1060

1.45

5.07

1.3

1.2

1.63

1.34

nmol/l

2.35

151

966

COPD related to multimorbidity

206

1244

1.40

5.07

1.4

1.2

1.63

1.40

nmol/l

1.68

187

1126

Haemorrhage in early pregnancy

579

1.63

5.06

1.5

1.4

1.51

1.49

nmol/l

0.08

520

Sleep disorders

453

2610

1.26

5.04

1.5

1.3

1.51

1.42

nmol/l

0.89

421

2348

Hepatic failure, not elsewhere classified

2.66

5.00

1.2

1.4

1.13

1.37

nmol/l

0.50

Oxicams

135

500

1.54

4.97

1.2

1.3

1.70

1.36

nmol/l

2.28

123

455

Venous thromboembolism

271

1967

1.33

4.97

1.3

1.56

1.42

nmol/l

1.22

245

1781

Disorders of vitreous body

249

1785

1.35

4.96

1.4

1.3

1.56

1.42

nmol/l

1.07

213

1611

ILD medications: azathioprine

425

1.75

4.96

1.4

1.3

1.71

1.37

nmol/l

1.46

374

Toxic liver disease

3.73

4.95

1.7

1.1

1.26

1.59

nmol/l

0.39

Other respiratory disorders and diseases

103

646

1.60

4.94

1.4

1.3

1.51

1.49

nmol/l

0.07

576

Other diseases of the respiratory system

103

646

1.60

4.94

1.4

1.3

1.51

1.49

nmol/l

0.07

576

Speech and linguistic disorders

185

2.14

4.91

1.4

1.3

1.66

1.35

nmol/l

0.94

164

Maternal care for known or suspected abnormality of pelvic organs

104

439

1.62

4.91

1.7

1.4

1.52

1.44

nmol/l

0.31

392

Viral and other specified intestinal infections

586

1.62

4.90

1.5

1.3

1.59

1.40

nmol/l

0.75

542

Hypotension

525

1.66

4.87

1.5

1.3

1.28

1.46

nmol/l

0.99

468

Fibroblastic disorders

117

759

1.55

4.86

1.4

1.3

1.25

1.43

nmol/l

1.14

105

688

Benign neoplasm: Ascending colon

473

1.70

4.85

1.3

1.69

1.47

nmol/l

0.85

419

Diseases of male genital organs

320

1230

1.32

4.83

1.3

1.41

1.37

nmol/l

0.23

285

1117

Diseases of salivary glands

161

1118

1.44

4.80

1.4

1.76

1.44

nmol/l

2.72

149

1001

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

515

2679

1.23

4.79

1.4

1.3

1.49

1.42

nmol/l

0.77

464

2423

Lichen simplex chronicus and prurigo

190

2.12

4.73

1.2

1.3

1.50

1.36

nmol/l

0.38

170

Other arthrosis

283

1484

1.32

4.73

1.4

1.3

1.54

1.36

nmol/l

1.89

253

1345

Acne

230

2.01

4.72

1.6

1.5

1.17

1.42

nmol/l

0.90

215

Stroke, excluding SAH

305

1706

1.31

4.71

1.2

1.3

1.52

1.40

nmol/l

1.03

267

1554

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

178

1258

1.41

4.70

1.5

1.4

1.58

1.44

nmol/l

0.84

168

1132

Other diseases of blood and blood-forming organs, wide

114

742

1.54

4.69

1.2

1.3

1.42

1.50

nmol/l

0.37

103

668

Undetermined asthma

366

1.78

4.67

1.4

1.3

1.61

1.47

nmol/l

0.38

329

Other disorders of bone

100

633

1.59

4.65

1.6

1.3

1.71

1.45

nmol/l

1.17

566

Stroke, including SAH

323

1814

1.29

4.63

1.3

1.50

1.41

nmol/l

0.71

284

1651

Symptoms and signs involving the urinary system

394

2386

1.26

4.59

1.3

1.52

1.42

nmol/l

0.89

344

2163

Conjunctivitis (acute, non atopic)

139

944

1.47

4.58

1.3

1.4

1.50

1.45

nmol/l

0.22

122

845

Diagnoses used for exclusion with ILD

130

875

1.49

4.57

1.3

1.51

1.45

nmol/l

0.25

111

784

Functional dyspepsia

128

859

1.49

4.57

1.3

1.48

1.47

nmol/l

0.05

111

769

Disorders of calcium metabolism

154

2.22

4.53

1.1

1.3

1.70

1.45

nmol/l

0.53

137

Exposure to other specified factors

390

2856

1.26

4.52

1.5

1.3

1.43

nmol/l

0.04

350

2583

Ovarian cyst

155

614

1.46

4.50

1.4

1.41

1.40

nmol/l

0.03

138

552

Disorders of mineral metabolism

221

2.00

4.50

1.2

1.3

1.70

1.44

nmol/l

0.71

197

Other surgical follow-up care

2.67

4.50

1.2

1.5

1.50

1.43

nmol/l

0.13

Sarcoidosis

446

1.69

4.48

1.2

1.3

1.60

1.45

nmol/l

0.55

402

Ischaemic Stroke, excluding all haemorrhages

281

1599

1.31

4.45

1.2

1.3

1.53

1.41

nmol/l

0.99

251

1454

Other enthesopathies

144

995

1.45

4.44

1.4

1.3

1.37

1.43

nmol/l

0.36

129

899

Superficial injury of thorax

486

1.65

4.41

1.6

1.3

1.37

1.50

nmol/l

0.48

438

Other disorders of kidney and ureter

433

1.70

4.41

1.5

1.3

1.67

1.50

nmol/l

0.51

386

Other diseases of arteries and capillaries

258

1.91

4.39

1.4

1.3

1.53

1.47

nmol/l

0.12

228

Type1 diabetes, definitions combined, early onset

149

2.22

4.39

1.2

1.4

0.56

1.38

nmol/l

4.63

134

Cerebral palsy and other paralytic syndromes

337

1.79

4.39

1.3

1.39

1.47

nmol/l

0.18

304

Iridocyclitis

115

763

1.51

4.36

1.5

1.3

1.36

1.46

nmol/l

0.51

105

683

Azathioprine

442

1.68

4.36

1.4

1.3

1.71

1.38

nmol/l

1.44

389

Other arthritis (FG)

153

1074

1.43

4.35

1.3

1.69

1.35

nmol/l

3.33

136

972

Other diseases of upper respiratory tract

584

2524

1.21

4.32

1.4

1.3

1.41

1.42

nmol/l

0.10

519

2288

Inflammatory disease of uterus

346

1.77

4.32

1.4

1.5

1.71

1.51

nmol/l

0.86

311

Supplementary factors related to causes of morbidity and mortality classified elsewhere

156

1102

1.42

4.29

1.3

1.57

1.44

nmol/l

0.80

145

978

Neoplasms

406

1721

1.25

4.26

1.4

1.3

1.42

1.41

nmol/l

0.09

367

1555

Other specified/unspecified arthritis

135

931

1.45

4.23

1.3

1.71

1.36

nmol/l

2.95

120

847

Other infectious diseases

276

1.86

4.22

1.2

1.3

1.56

1.44

nmol/l

0.25

246

Fracture of shoulder and upper arm

172

1238

1.39

4.22

1.4

1.3

1.26

1.40

nmol/l

1.11

161

1112

Psychotic depression

127

2.30

4.19

1.3

1.49

1.45

nmol/l

0.07

116

Acute suppurative otitis media

122

770

1.48

4.18

1.4

1.40

nmol/l

0.01

109

701

Monoamine oxidase A inhibitors

335

1.77

4.18

1.3

1.70

1.42

nmol/l

0.78

294

Otitis externa, unspecified

328

1.78

4.16

1.5

1.3

1.53

1.43

nmol/l

0.28

297

Biological medication for rheuma

533

1.60

4.15

1.4

1.3

1.64

1.43

nmol/l

0.92

485

Cardiomyopathy, other and unspecified

235

1.93

4.15

1.3

1.2

1.87

1.41

nmol/l

1.46

209

Strabismus

127

868

1.46

4.13

1.3

1.4

1.52

1.44

nmol/l

0.36

112

777

Other diseases of intestine

473

1.64

4.10

1.4

1.3

1.52

1.46

nmol/l

0.15

421

Fracture of lumbar spine and pelvis

103

676

1.53

4.10

1.4

1.3

1.21

1.49

nmol/l

1.90

601

Preterm labour and delivery

107

709

1.51

4.10

1.4

1.37

1.50

nmol/l

0.73

639

Acute and transient psychotic disorders

368

1.72

4.06

1.2

1.3

1.63

1.41

nmol/l

0.90

328

Disorders of tooth development and eruption

356

1.66

4.05

1.5

1.3

1.50

1.45

nmol/l

0.12

321

Nonorganic sleeping disorders

641

1.53

4.00

1.3

1.4

1.44

1.40

nmol/l

0.13

577

Hyperparathyroidism

518

1.59

3.96

1.2

1.3

1.61

1.45

nmol/l

0.62

466

Abnormal involuntary movements

424

1.66

3.95

1.4

1.3

1.72

1.50

nmol/l

0.79

387

Abnormal findings on examination of urine, without diagnosis

131

2.23

3.93

1.8

1.3

1.77

1.37

nmol/l

1.23

116

Superficial injury of abdomen, lower back and pelvis

463

1.63

3.93

1.7

1.3

1.12

1.46

nmol/l

2.24

418

Arthropod-borne viral fevers and viral haemorrhagic fevers

605

1.54

3.90

1.3

1.37

1.48

nmol/l

0.38

546

Disorders of psychological development

262

1.81

3.89

1.3

1.4

1.67

1.35

nmol/l

1.22

235

Other bacterial intestinal infections

107

718

1.49

3.89

1.6

1.3

1.45

1.47

nmol/l

0.06

651

Adhesive capsulitis of shoulder

535

1.58

3.88

1.3

1.32

1.51

nmol/l

0.84

483

Acute and subacute iridocyclitis

631

1.53

3.85

1.5

1.3

1.35

1.46

nmol/l

0.48

563

Organic, including symptomatic, mental disorders

235

1277

1.31

3.81

1.2

1.3

1.31

1.46

nmol/l

1.40

216

1149

Bacterial pneumonia, not elsewhere classified

184

1199

1.35

3.81

1.3

1.41

1.38

nmol/l

0.18

172

1080

Insomnia

430

2571

1.22

3.80

1.5

1.3

1.51

1.43

nmol/l

0.82

400

2312

Menorrhagia

147

575

1.42

3.77

1.4

1.61

1.39

nmol/l

1.59

134

518

Irritable bowel syndrome

127

888

1.43

3.75

1.8

1.3

1.45

1.43

nmol/l

0.10

119

798

Diabetic retinopathy

523

2731

1.20

3.74

1.3

1.16

1.48

nmol/l

10.75

430

2517

Anterior Iridocyclitis

101

677

1.50

3.71

1.5

1.3

1.33

1.48

nmol/l

0.77

604

Pain in thoracic spine

463

1.60

3.70

1.3

1.67

1.41

nmol/l

1.19

408

Dilated cardiomyopathy

425

1.63

3.68

1.2

1.3

1.83

1.46

nmol/l

1.58

373

Panniculitis affecting regions of neck and back

103

2.35

3.67

1.5

1.2

1.67

1.26

nmol/l

0.93

Injuries to the wrist and hand

512

2969

1.20

3.67

1.4

1.3

1.39

1.44

nmol/l

0.57

459

2689

Transient ischemic attack

247

1550

1.29

3.66

1.3

1.45

1.40

nmol/l

0.25

215

1407

Alzheimer disease, excluding more controls

296

1.63

3.64

1.2

1.15

1.44

nmol/l

2.27

267

Plantar fascial fibromatosis

261

1.81

3.63

1.3

1.46

1.44

nmol/l

0.05

236

Operations 2 for CAVS

133

915

1.41

3.62

1.2

1.55

1.42

nmol/l

0.58

126

818

Calcific aortic valvular stenosis, diagnosis (helper)

133

915

1.41

3.62

1.2

1.55

1.42

nmol/l

0.58

126

818

Other disorders of ear

477

2600

1.20

3.61

1.3

1.49

1.42

nmol/l

0.64

425

2354

Calcific aortic valvular stenosis, operated

133

916

1.41

3.60

1.2

1.55

1.42

nmol/l

0.59

126

819

Calcific aortic valvular stenosis

133

916

1.41

3.60

1.2

1.55

1.42

nmol/l

0.59

126

819

Paralytic ileus and intestinal obstruction

123

862

1.43

3.59

1.3

1.46

1.40

nmol/l

0.22

112

770

Deforming dorsopathies

127

897

1.42

3.57

1.3

1.45

1.44

nmol/l

0.06

107

794

D07AA Corticosteroids, weak (group I)

428

1.62

3.56

1.5

1.3

1.72

1.42

nmol/l

1.25

387

Calcific aortic valvular stenosis, including rheumatic fever

133

918

1.41

3.54

1.2

1.55

1.43

nmol/l

0.58

126

821

COPD

217

1360

1.31

3.53

1.4

1.3

1.61

1.36

nmol/l

2.18

196

1234

Coxibs

142

530

1.41

3.52

1.4

1.3

1.55

1.36

nmol/l

1.10

125

483

Other bacterial intestinal infections

541

1.54

3.50

1.7

1.3

1.41

1.48

nmol/l

0.23

485

Need for other prophylactic measures

179

1.97

3.48

1.3

1.13

1.40

nmol/l

0.89

159

Other symptoms and signs involving the circulatory and respiratory systems

179

1.97

3.48

1.3

1.2

1.81

1.51

nmol/l

0.64

164

Enlarged lymph nodes

463

1.58

3.47

1.3

1.50

1.49

nmol/l

0.04

410

Viral haemorrhagic fevers, not elsewhere classified/unspecified

534

1.54

3.47

1.3

1.31

1.52

nmol/l

0.95

481

Malignant neoplasm of prostate, including Hilmo

832

0.68

3.45

1.3

1.2

1.36

1.43

nmol/l

0.34

754

Artrosis, including avohilmo

438

1984

1.21

3.45

1.4

1.3

1.55

1.38

nmol/l

2.34

393

1785

Malignant neoplasm of prostate

793

0.67

3.42

1.4

1.2

1.45

1.44

nmol/l

0.03

719

Other disorders of lacrimal gland

159

1176

1.36

3.41

1.4

1.3

1.53

1.47

nmol/l

0.30

141

1053

Iron deficiency anaemia secondary to blood loss (chronic)

489

1.56

3.41

1.2

1.3

1.57

1.49

nmol/l

0.22

437

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.47

3.39

1.2

1.42

1.49

nmol/l

0.09

malignant neoplasm of male genital organs

834

0.68

3.38

1.3

1.2

1.42

nmol/l

0.01

757

L04AX Other immunosuppressants

270

2154

1.26

3.29

1.4

1.3

1.58

1.42

nmol/l

1.71

244

1940

Other orthopaedic follow-up care

169

1.97

3.29

1.3

1.4

1.41

1.35

nmol/l

0.09

149

Thyrotoxicosis, other and/or unspecified

590

1.50

3.28

1.4

1.40

1.46

nmol/l

0.16

535

Medical abortion

245

1038

1.28

3.26

1.3

1.31

1.54

nmol/l

2.68

218

940

Other systemic involvement of connective tissue (FG)

111

769

1.43

3.26

1.4

1.3

1.65

1.37

nmol/l

1.66

103

688

Hyperkinetic disorders

279

1.72

3.26

1.6

1.5

1.85

1.31

nmol/l

2.09

253

Benign neoplasm of ovary

455

1.57

3.25

1.2

1.4

1.74

1.44

nmol/l

1.21

409

Second line medication for Crohn's disease

277

2220

1.25

3.25

1.4

1.3

1.57

1.42

nmol/l

1.55

251

2000

Mouth breathing

208

1609

1.29

3.25

1.3

1.62

1.40

nmol/l

1.58

185

1451

Nail disorders

264

1.75

3.23

1.2

1.3

1.58

1.51

nmol/l

0.16

239

Disorders of parathyroid gland

601

1.48

3.22

1.2

1.3

1.60

1.46

nmol/l

0.58

543

Primary gonarthrosis, bilateral

247

1674

1.27

3.19

1.4

1.3

1.76

1.40

nmol/l

4.91

222

1508

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

319

2326

1.23

3.19

1.3

1.43

nmol/l

0.01

283

2108

Ulcerative colitis, NAS

442

1.57

3.18

1.4

1.3

1.59

1.41

nmol/l

0.61

399

Pulmonary heart disease, diseases of pulmonary circulation

143

1054

1.36

3.16

1.3

1.69

1.42

nmol/l

1.83

125

951

Inflammatory bowel disease

153

1140

1.35

3.16

1.5

1.4

1.41

1.47

nmol/l

0.27

137

1014

Other joint disorders

436

1919

1.20

3.16

1.4

1.3

1.53

1.37

nmol/l

1.93

387

1749

Polyarthrosis

582

1.47

3.15

1.4

1.3

1.68

1.41

nmol/l

1.44

529

Chronic sinusitis

206

1600

1.29

3.14

1.5

1.3

1.40

1.44

nmol/l

0.21

183

1440

Injuries to the hip and thigh

219

1552

1.28

3.13

1.3

1.51

1.40

nmol/l

0.71

194

1408

Other chronic obstructive pulmonary disease

207

1325

1.29

3.11

1.4

1.3

1.63

1.36

nmol/l

2.28

187

1202

Herpesviral [herpes simplex] infections

351

1.63

3.10

1.2

1.3

1.42

1.45

nmol/l

0.08

317

Disorders of eyelid, lacrimal system and orbit

416

2647

1.19

3.07

1.3

1.44

1.43

nmol/l

0.07

377

2396

Spondylolisthesis/Spondylolysis

591

1.48

3.07

1.3

1.42

nmol/l

0.00

522

Car occupant injured in other and unspecified transport accidents

583

1.48

3.06

1.3

1.37

1.45

nmol/l

0.32

522

Type of accident

138

1018

1.36

3.06

1.3

1.59

1.45

nmol/l

0.84

127

906

DVT of lower extremities and pulmonary embolism

191

1470

1.30

3.05

1.3

1.65

1.40

nmol/l

2.13

172

1326

Coxarthrosis

253

1331

1.26

3.00

1.5

1.3

1.59

1.35

nmol/l

2.84

225

1211

Oter anti-inflammatory and antirheumatic agents, non-steroids

119

467

1.41

3.00

1.4

1.3

1.62

1.37

nmol/l

1.43

107

428

Disturbances of skin sensation

127

928

1.37

3.00

1.3

1.4

1.42

1.47

nmol/l

0.20

120

831

Impotence

212

1.81

2.96

1.4

1.2

1.39

1.51

nmol/l

0.24

189

Disorders of conjunctiva

393

2645

1.19

2.92

1.3

1.50

1.43

nmol/l

0.59

347

2397

Pericarditis

2.23

2.90

1.3

1.2

1.63

1.36

nmol/l

0.44

Other disorders involving the immune mechanism, not elsewhere classified

2.27

2.88

1.2

1.42

1.43

nmol/l

0.01

Reimbursement for rheumatic diseases

261

2106

1.24

2.84

1.4

1.3

1.54

1.42

nmol/l

1.00

237

1895

Ulcerative colitis

116

845

1.38

2.81

1.4

1.3

1.42

1.45

nmol/l

0.08

103

754

Salpingitis and oophoritis

488

1.50

2.81

1.4

1.54

1.48

nmol/l

0.18

441

Other condition

464

1.51

2.81

1.1

1.3

1.42

1.45

nmol/l

0.07

423

Other and unspecified urticaria

586

1.45

2.81

1.7

1.3

1.30

1.45

nmol/l

0.66

527

Nonischemic cardiomyopathy

268

1.68

2.80

1.2

1.3

1.66

1.39

nmol/l

0.85

245

Benign neoplasm: Duodenum

2.49

2.80

1.5

1.1

1.51

1.53

nmol/l

0.03

Abnormal findings on diagnostic imaging of other body structures

449

1.52

2.78

1.3

1.40

1.51

nmol/l

0.36

403

Valvular heart disease excluding rheumatic fever

215

1228

1.27

2.78

1.3

1.48

1.39

nmol/l

0.61

190

1113

Malignant neoplasm, wide definition for exclusion

456

2274

1.18

2.77

1.3

1.46

1.44

nmol/l

0.09

412

2058

Epilepsy

127

940

1.35

2.74

1.4

1.3

1.50

1.32

nmol/l

1.16

112

839

Appendicitis, broad definition

371

2823

1.19

2.73

1.4

1.3

1.53

1.42

nmol/l

1.14

338

2549

Rheumatoid arthritis

144

976

1.33

2.72

1.4

1.3

1.61

1.37

nmol/l

1.65

130

885

Adalimumab

286

1.65

2.72

1.5

1.3

1.68

1.48

nmol/l

0.53

260

Non-rheumatic valve diseases

213

1218

1.26

2.72

1.3

1.48

1.39

nmol/l

0.62

188

1104

Tumor necrosis factor alpha inhibitors

468

1.50

2.71

1.5

1.3

1.59

1.39

nmol/l

0.82

423

Other viral diseases

167

1283

1.29

2.69

1.5

1.3

1.36

1.46

nmol/l

0.56

148

1157

Conjunctivitis

349

2441

1.20

2.68

1.4

1.3

1.46

1.43

nmol/l

0.16

308

2211

Diseases of appendix

373

2836

1.19

2.67

1.4

1.3

1.53

1.43

nmol/l

1.11

340

2559

Maternal care for known or suspected fetal abnormality and damage

306

1.58

2.67

1.3

1.4

1.38

1.50

nmol/l

0.37

276

Infections with a predominantly sexual mode of transmission

129

964

1.34

2.65

1.4

1.24

1.47

nmol/l

1.84

107

874

Recurrent aphthous stomatitis , including avohilmo

414

1.53

2.65

1.5

1.3

1.36

1.48

nmol/l

0.48

377

Disturbance of activity and attention

252

1.68

2.65

1.7

1.5

1.83

1.34

nmol/l

1.51

232

Sequelae of injuries of lower limb

296

1.63

2.65

1.5

1.3

1.24

1.43

nmol/l

0.64

266

False labour

105

469

1.40

2.64

1.3

1.54

1.41

nmol/l

0.59

424

Arthropod-borne viral fevers and viral haemorrhagic fevers

320

1.60

2.63

1.4

1.3

1.54

1.46

nmol/l

0.17

289

Diabetic retinopathy, strict definition

265

1919

1.23

2.63

1.3

1.02

1.47

nmol/l

13.02

201

1769

Other maltreatment syndromes

2.17

2.61

1.2

1.3

1.01

1.38

nmol/l

0.95

Thyroiditis, ILD-related definition

297

1.62

2.61

1.2

1.4

1.31

1.50

nmol/l

0.53

262

Stomatitis and related lesions

613

1.42

2.59

1.4

1.3

1.29

1.46

nmol/l

0.98

550

Other disorders of penis

353

1.57

2.58

1.2

1.39

nmol/l

0.00

317

Methotrexate

409

1.52

2.57

1.4

1.3

1.69

1.45

nmol/l

0.97

363

Benign neoplasm: Rectum, anus and anal canal

681

1.40

2.57

1.4

1.3

1.65

1.48

nmol/l

0.63

608

Acute appendicitis, no complications

274

2251

1.21

2.54

1.5

1.3

1.50

1.42

nmol/l

0.56

251

2024

Suppurative and unspecified otitis media

157

1076

1.29

2.53

1.3

1.4

1.47

1.42

nmol/l

0.20

136

977

Coxarthrosis [arthrosis of hip](FG)

268

1547

1.22

2.53

1.5

1.3

1.60

1.32

nmol/l

3.93

240

1402

Other diseases of anus and rectum

134

1015

1.32

2.52

1.3

1.57

1.39

nmol/l

0.86

116

910

Other viral diseases

131

989

1.32

2.51

1.5

1.3

1.36

1.45

nmol/l

0.43

114

887

Diplopia

428

1.50

2.51

1.6

1.3

1.71

1.51

nmol/l

0.66

384

COPD (mode)

145

872

1.31

2.49

1.4

1.2

1.63

1.38

nmol/l

1.38

130

792

Other viral diseases, not elsewhere classified

592

1.42

2.48

1.6

1.3

1.30

1.45

nmol/l

0.58

534

Bacterial intestinal infections, IBD co-morbidities

586

1.42

2.46

1.7

1.3

1.40

1.50

nmol/l

0.33

520

Other embolism and thrombosis

414

1.50

2.45

1.2

1.3

1.54

1.49

nmol/l

0.15

372

Other infectious diseases

233

1.68

2.45

1.2

1.3

1.67

1.44

nmol/l

0.47

207

173

1249

1.27

2.45

1.3

1.2

1.42

1.44

nmol/l

0.12

150

1133

Premature rupture of membranes

369

1.46

2.44

1.5

1.4

1.47

nmol/l

0.01

331

Benign neoplasm of other and unspecified endocrine glands

431

1.49

2.43

1.4

1.3

1.39

1.50

nmol/l

0.38

390

Maternal care for known or suspected malpresentation of fetus

309

1.50

2.43

1.9

1.4

1.32

1.49

nmol/l

0.69

278

489

1.44

2.43

1.3

1.2

1.49

1.48

nmol/l

0.03

441

Benign neoplasm: Adrenal gland

249

1.66

2.43

1.5

1.3

1.26

1.48

nmol/l

0.73

226

Impingement syndrome of shoulder

115

860

1.34

2.42

1.4

1.2

1.56

1.42

nmol/l

0.59

101

783

Intestinal stricture

139

1068

1.30

2.41

1.5

1.3

1.45

1.42

nmol/l

0.11

126

959

Atopic dermatitis, strict definition with reimbursement

125

913

1.32

2.41

1.4

1.47

1.41

nmol/l

0.26

117

818

Other arrhythmias

292

1834

1.20

2.41

1.5

1.3

1.58

1.40

nmol/l

1.91

269

1653

Restless leg syndrome

400

1.51

2.40

1.5

1.3

1.38

1.48

nmol/l

0.28

364

Other specified/unspecified spondylopathies

2.36

2.39

1.6

1.2

1.75

1.30

nmol/l

0.95

Toxic effect of carbon monoxide

2.64

2.37

2.1

1.2

1.44

1.63

nmol/l

0.24

Fitting and adjustment of other devices

155

1092

1.28

2.37

1.2

1.3

1.56

1.41

nmol/l

0.90

139

995

Fall on same level involving ice and snow

261

2162

1.21

2.36

1.4

1.3

1.50

1.41

nmol/l

0.67

237

1949

Other acute viral hepatitis

2.86

2.35

1.2

1.17

1.45

nmol/l

0.40

Fall on and from stairs and steps

115

864

1.33

2.35

1.4

1.3

1.27

1.47

nmol/l

1.16

772

Spontaneous abortion

172

913

1.27

2.35

1.5

1.4

1.43

1.55

nmol/l

0.82

154

825

Symptoms and signs involving the skin and subcutaneous tissue

332

2751

1.18

2.35

1.3

1.53

1.44

nmol/l

0.80

305

2487

Retinal detachments and breaks

150

1170

1.28

2.34

1.3

1.31

1.47

nmol/l

1.03

133

1070

Sequelae of cerebrovascular disease

159

1075

1.28

2.34

1.2

1.3

1.43

1.40

nmol/l

0.09

144

975

Systemic connective tissue disorders

148

1153

1.29

2.33

1.4

1.3

1.66

1.45

nmol/l

1.35

135

1033

Female infertility

116

525

1.34

2.32

1.6

1.4

1.62

1.40

nmol/l

1.25

108

471

Benign neoplasm: Rectum

619

1.39

2.31

1.4

1.3

1.69

1.49

nmol/l

0.68

555

Other symptoms and signs involving the digestive system and abdomen

428

1.48

2.31

1.4

1.2

1.45

nmol/l

0.01

382

Other viral diseases, not elsewhere classified

115

862

1.33

2.30

1.5

1.4

1.27

1.43

nmol/l

0.83

104

767

Ectopic pregnancy

461

1.46

2.30

1.5

1.4

1.43

1.60

nmol/l

0.72

420

Other and unspecified visual disturbances

301

1.57

2.27

1.2

1.3

1.43

1.54

nmol/l

0.31

272

Pregnancy with abortive outcome

246

1052

1.22

2.27

1.5

1.3

1.31

1.54

nmol/l

2.81

219

952

Diaphragmatic hernia

161

1273

1.27

2.26

1.5

1.3

1.26

1.45

nmol/l

1.67

145

1146

Somatoform disorder

463

1.45

2.26

1.5

1.3

1.98

1.44

nmol/l

1.98

419

Chronic rhinitis, nasopharyngitis and pharyngitis

147

1150

1.28

2.25

1.3

1.49

1.44

nmol/l

0.23

130

1032

Foreign body in alimentary tract

149

1.82

2.24

1.5

1.4

1.65

1.43

nmol/l

0.55

134

Carbimazole or st.post thyroidectomy, condition for graves disease

623

1.38

2.24

1.4

1.3

1.25

1.48

nmol/l

1.50

562

Viral warts

683

1.36

2.23

1.5

1.3

1.42

1.44

nmol/l

0.06

608

IgA nephropathy (IgA glomerulonephritis)

2.21

2.22

1.3

1.2

1.37

1.57

nmol/l

0.25

Seronegative rheumatoid arthritis

351

1.52

2.21

1.5

1.3

1.66

1.43

nmol/l

0.69

321

Dementia, including avohilmo

188

1039

1.25

2.19

1.2

1.3

1.22

1.48

nmol/l

3.69

171

937

Acute appendicitis

343

2740

1.17

2.18

1.5

1.3

1.53

1.42

nmol/l

0.95

311

2476

Other/unspecified synovitis and tenosynovitis

320

1.54

2.18

1.2

1.3

1.61

1.48

nmol/l

0.25

288

Enterocolitis due to Clostridium difficile

329

1.53

2.16

1.6

1.3

1.28

1.50

nmol/l

0.62

295

Other respiratory diseases principally affecting the interstitium

586

1.39

2.14

1.3

1.60

1.45

nmol/l

0.49

516

Propionic acid derivatives

140

544

1.30

2.13

1.3

1.39

1.35

nmol/l

0.17

125

496

Spondyloarthritis

562

1.39

2.11

1.4

1.3

1.57

1.47

nmol/l

0.33

500

Other chronic obstructive pulmonary disease, including avohilmo

255

1761

1.20

2.10

1.4

1.3

1.63

1.39

nmol/l

2.39

232

1596

Psoriatic and enteropathic arthropathies

372

1.48

2.09

1.4

1.3

1.44

1.41

nmol/l

0.08

336

Pulmonary heart disease

127

986

1.29

2.09

1.3

1.70

1.42

nmol/l

1.70

114

888

Dermatopolymyositis

2.73

2.08

1.9

1.1

2.00

1.51

nmol/l

—

Pulmonary embolism

127

987

1.29

2.08

1.3

1.70

1.43

nmol/l

1.68

114

889

Malignant neoplasm of larynx, including Hilmo

0.00

2.07

0.0

1.2

—

1.48

—

Disorders of lacrimal system

180

1455

1.24

2.07

1.4

1.3

1.51

1.45

nmol/l

0.30

162

1309

Maltreatment syndromes

132

1.83

2.03

2.0

1.5

1.71

1.37

nmol/l

0.66

121

Persons encountering health services in circumstances related to reproduction

201

1646

0.82

2.03

1.4

1.3

1.44

1.43

nmol/l

0.05

189

1476

COPD, hospital admission 2, with asthma infections

144

976

1.27

2.02

1.5

1.3

1.62

1.39

nmol/l

1.36

131

879

Mandibular retrognathia

177

0.39

2.02

1.3

1.4

1.25

1.43

nmol/l

—

165

Other articular cartilage disorders

2.24

2.01

1.9

1.2

2.30

1.54

nmol/l

0.85

Pneumonia due to other infectious organisms, not elsewhere classified

1.97

2.00

1.5

1.2

1.32

1.52

nmol/l

0.40

Cardiac murmurs and other cardiac sounds

221

1.61

2.00

1.3

1.46

1.43

nmol/l

0.07

204

Superficial injury of forearm

271

1.56

2.00

1.6

1.3

1.83

1.51

nmol/l

0.84

242

Coeliac disease

344

1.49

1.98

1.5

1.3

1.36

1.46

nmol/l

0.24

310

Superficial injury of wrist and hand

655

1.35

1.97

1.4

1.3

1.54

1.42

nmol/l

0.39

592

Coagulation defects, purpura and other haemorrhagic conditions

621

1.36

1.97

1.2

1.3

1.56

1.49

nmol/l

0.23

554

Appendectomy

306

2503

1.17

1.97

1.5

1.3

1.52

1.43

nmol/l

0.65

275

2260

Other noninflammatory disorders of uterus, except cervix

432

1.36

1.96

1.3

1.58

1.39

nmol/l

0.89

391

Unspecified fall

223

1832

1.20

1.95

1.3

1.32

1.41

nmol/l

0.73

202

1651

Malignant neoplasm

429

2218

1.15

1.95

1.3

1.46

1.44

nmol/l

0.12

384

2007

Other systemic involvement of connective tissue

113

874

1.30

1.94

1.3

1.64

1.46

nmol/l

0.88

105

784

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

136

1077

1.27

1.94

1.6

1.3

1.34

1.42

nmol/l

0.39

123

964

Secondary parkinsonism, excluding more controls

2.46

1.93

1.2

1.63

1.61

nmol/l

0.02

Ocular pain

234

1.59

1.93

1.6

1.4

1.32

1.46

nmol/l

0.37

209

Thyrotoxicosis

103

788

1.31

1.92

1.3

1.46

1.49

nmol/l

0.10

705

Anti-inflammatory and antirheumatic products, non-steroids

138

544

1.28

1.92

1.2

1.3

1.42

1.35

nmol/l

0.29

124

496

Disorders of ocular muscles, binocular movement, accommodation and refraction

205

1684

1.21

1.92

1.4

1.3

1.46

1.44

nmol/l

0.10

184

1517

Other disorders of eyelid

189

1479

1.22

1.91

1.3

1.39

1.44

nmol/l

0.25

179

1330

Radial styloid tenosynovitis [de Quervain]

128

1.80

1.89

1.7

1.3

2.02

1.34

nmol/l

1.37

119

Maternal care related to the fetus and amniotic cavity and possible delivery problems

158

743

1.25

1.89

1.7

1.3

1.65

1.44

nmol/l

1.54

143

669

Orthopaedic devices associated with adverse incidents

0.00

1.89

0.0

1.1

—

1.58

—

Atopic dermatitis, strict definition

119

911

1.28

1.89

1.4

1.49

1.43

nmol/l

0.24

111

823

Dislocation, sprain and strain of joints and ligaments at neck level

465

1.40

1.87

1.6

1.4

1.52

1.45

nmol/l

0.13

419

Benign paroxysmal vertigo

126

994

1.27

1.87

1.4

1.3

1.49

1.46

nmol/l

0.09

117

890

Melanocytic naevi, other sites/unspecified

236

1.57

1.87

1.5

1.4

1.57

1.49

nmol/l

0.14

208

Benign neoplasm: Sigmoid colon

662

1.33

1.86

1.3

1.60

1.52

nmol/l

0.29

590

Primary open-angle glaucoma

126

961

1.27

1.86

1.2

1.3

1.35

1.46

nmol/l

0.52

115

868

Herpesviral [herpes simplex] infections

101

776

1.30

1.84

1.3

1.4

1.54

1.44

nmol/l

0.39

698

Abnormal results of function studies

293

1.51

1.84

1.4

1.3

1.51

1.52

nmol/l

0.02

262

Visual field defects

253

1.55

1.84

1.3

1.40

1.43

nmol/l

0.06

228

Seropositive rheumatoid arthritis

103

791

1.30

1.83

1.3

1.64

1.37

nmol/l

1.56

710

Conductive and sensorineural hearing loss

385

2269

1.15

1.82

1.3

1.48

1.43

nmol/l

0.44

347

2056

Otitis media, unspecified

255

1.52

1.82

1.3

1.71

1.35

nmol/l

0.98

233

Carcinoma in situ of colon

2.29

1.81

1.4

1.1

1.21

1.67

nmol/l

0.85

Hepatocellular carcinoma

2.28

1.81

1.2

1.98

1.60

nmol/l

0.38

Congenital deformities of feet

1.93

1.80

1.2

1.5

1.56

1.27

nmol/l

0.43

Macular pucker

452

1.40

1.80

1.2

1.41

1.56

nmol/l

0.47

409

Burns classified according to extent of body surface involved

2.80

1.80

1.3

1.1

1.14

1.53

nmol/l

—

COPD, early/later onset

208

1463

1.20

1.79

1.4

1.3

1.62

1.39

nmol/l

1.85

188

1325

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

402

1.42

1.79

1.6

1.4

1.71

1.50

nmol/l

0.65

362

Toxic effect of contact with venomous animals

109

1.85

1.77

1.5

1.4

1.12

1.39

nmol/l

0.58

Ulcerative colitis (strict definition, all Crohn cases excluded)

462

1.39

1.77

1.3

1.44

1.40

nmol/l

0.11

411

Schizotypal disorder

2.11

1.76

1.1

1.2

1.63

1.31

nmol/l

0.83

Viral warts

280

1.50

1.76

1.4

1.3

1.75

1.45

nmol/l

0.89

251

Hypermobility syndrome

124

1.78

1.76

1.3

1.5

2.10

1.50

nmol/l

1.01

112

Meniscus derangement

271

1559

1.17

1.75

1.5

1.3

1.53

1.36

nmol/l

1.66

242

1416

IBD patients in KELA-register

103

800

1.29

1.75

1.4

1.3

1.53

1.44

nmol/l

0.37

716

Diseases of the myoneural junction and muscle

396

1.42

1.75

1.5

1.3

1.56

1.53

nmol/l

0.08

357

Papilloedema, unspecified

2.24

1.74

1.6

1.3

1.05

1.48

nmol/l

1.11

Primary open-angle glaucoma, strict

104

808

1.29

1.73

1.2

1.3

1.31

1.46

nmol/l

0.91

722

Pilonidal cyst

249

1.53

1.73

1.5

1.3

1.54

1.38

nmol/l

0.43

229

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

298

1.48

1.72

1.4

1.3

1.21

1.47

nmol/l

0.85

268

Suggestive for eosinophilic asthma

290

1.49

1.71

1.6

1.3

1.24

1.43

nmol/l

0.62

263

Carcinoma in situ of other and unspecified genital organs

0.00

1.70

0.0

1.6

—

1.19

—

Immunodeficiency with predominantly antibody defects

2.02

1.70

1.1

1.2

1.82

1.42

nmol/l

0.42

Achilles tendinitis

332

1.45

1.69

1.4

1.3

1.61

1.39

nmol/l

0.62

292

Complications of labour and delivery

226

1058

1.19

1.69

1.4

1.52

1.50

nmol/l

0.10

202

958

Mucosal proctocolitis

399

1.41

1.68

1.4

1.3

1.53

1.38

nmol/l

0.44

359

Infections with a predominantly sexual mode of transmission

157

1198

1.22

1.68

1.4

1.22

1.47

nmol/l

2.48

131

1092

Myocardial infarction, unclassifiable

631

1.30

1.68

1.2

1.40

1.44

nmol/l

0.11

563

Heart failure and hypertrophic cardiomyopathy

2.20

1.68

1.4

1.1

1.86

1.68

nmol/l

0.20

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

528

1.35

1.66

1.4

1.3

1.45

1.43

nmol/l

0.08

469

Leiomyoma of uterus

236

1133

1.18

1.65

1.5

1.4

1.61

1.47

nmol/l

0.94

211

1024

COPD, hospital admissions

204

1450

1.19

1.65

1.4

1.3

1.63

1.39

nmol/l

2.01

185

1313

Malignant neoplasm of rectosigmoid junction

2.46

1.65

1.6

1.2

1.39

1.63

nmol/l

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

220

1.55

1.65

1.2

1.3

1.41

1.51

nmol/l

0.15

196

Inflammatory bowel disease, strict (require KELA)

103

808

1.28

1.64

1.4

1.3

1.53

1.44

nmol/l

0.38

723

Pyothorax

127

1.74

1.64

1.2

1.39

1.38

nmol/l

0.02

115

Migraine without aura and triptan purchases

453

1.37

1.62

1.4

1.5

1.52

1.44

nmol/l

0.24

399

Persons with potential health hazards related to communicable diseases

155

1264

1.22

1.62

1.5

1.4

1.35

1.45

nmol/l

0.60

142

1134

Other diseases of pleura

200

1476

1.19

1.61

1.4

1.3

1.44

1.40

nmol/l

0.20

180

1339

Poor fetal growth

286

1.47

1.61

1.5

1.6

1.52

1.49

nmol/l

0.07

260

Inflammatory disorders of breast

143

1.68

1.61

1.2

1.4

1.57

1.47

nmol/l

0.18

131

Chromosomal abnormalities, not elsewhere classified

2.15

1.60

1.3

1.4

1.83

1.36

nmol/l

0.72

Other skin changes

583

1.32

1.60

1.2

1.3

1.72

1.47

nmol/l

1.23

520

Acetic acid derivatives and related substances

127

526

1.26

1.60

1.4

1.3

1.60

1.37

nmol/l

1.25

115

479

Other otitis externa (chronic)

182

1.60

1.2

1.3

1.46

1.44

nmol/l

0.03

163

Disorders of eyelid in diseases classified elsewhere

1.92

1.60

1.3

1.4

1.84

1.42

nmol/l

0.62

Burns and corrosions of multiple and unspecified body regions

2.02

1.59

1.4

1.2

1.17

1.54

nmol/l

0.79

Actinic keratosis

150

1140

1.22

1.59

1.3

1.2

1.44

1.45

nmol/l

0.03

128

1034

Sexual dysfunction

2.35

1.59

1.1

1.2

1.28

1.41

nmol/l

—

Enthesopathies of lower limb, excluding foot

750

1.28

1.59

1.3

1.52

1.43

nmol/l

0.32

663

Open wound of head

252

2089

1.16

1.59

1.4

1.3

1.35

1.41

nmol/l

0.34

233

1882

Disorders of vestibular function (Vertigo)

200

1661

1.19

1.59

1.4

1.3

1.50

1.44

nmol/l

0.38

183

1492

Communicating hydrocephalus

2.22

1.57

1.4

1.2

1.23

1.51

nmol/l

0.44

Lateral epicondylitis

405

1.39

1.57

1.3

1.39

1.52

nmol/l

0.48

364

Discitis, unspecified

2.29

1.56

1.4

1.1

1.55

1.26

nmol/l

—

Disorder of the sleep-wake schedule

2.29

1.56

1.5

1.3

1.15

1.54

nmol/l

—

Congenital deformities of feet

2.04

1.54

1.3

1.39

1.22

nmol/l

0.20

DVT of lower extremities

622

1.31

1.54

1.4

1.2

1.59

1.48

nmol/l

0.35

556

Vascular dementia (mixed)

2.44

1.54

1.4

1.1

1.85

1.56

nmol/l

—

Other or unspecified ileus, impaction or obstruction

596

1.31

1.53

1.4

1.3

1.51

1.43

nmol/l

0.23

534

Transient global amnesia

284

0.56

1.52

1.1

1.3

1.41

1.49

nmol/l

0.16

254

Other (seronegative) rheumatoid arthritis, wide

597

1.31

1.52

1.4

1.3

1.63

1.49

nmol/l

0.44

538

Other disorders of eye and adnexa

399

1.38

1.52

1.5

1.3

1.57

1.48

nmol/l

0.24

362

Rheumatoid arthritis, including avohilmo

158

1313

1.21

1.52

1.4

1.3

1.61

1.44

nmol/l

1.08

144

1182

Malignant neoplasm of larynx

0.00

1.51

0.0

1.2

—

1.44

—

Suppurative and necrotic conditions of lower respiratory tract

177

1.59

1.51

1.2

1.42

1.43

nmol/l

0.01

161

Palmar fascial fibromatosis [Dupuytren]

485

1.34

1.51

1.5

1.2

1.06

1.42

nmol/l

2.12

436

Residual foreign body in soft tissue

146

1.65

1.51

1.3

1.2

1.48

1.40

nmol/l

0.15

133

Dementia in Alzheimer disease

358

1.37

1.50

1.2

1.19

1.48

nmol/l

1.57

320

Malignant neoplasm of liver and intrahepatic bile ducts

1.96

1.49

1.4

1.2

2.31

1.57

nmol/l

1.01

Bulimia nervosa (incl. atypical)

1.95

1.49

1.3

1.5

1.99

1.53

nmol/l

0.59

Female infertility, cervical, vaginal, other or unspecified origin

101

518

1.27

1.48

1.6

1.4

1.58

1.40

nmol/l

0.85

464

Crowding of teeth, including avohilmo

169

0.49

1.48

1.3

1.01

1.49

nmol/l

—

155

Other inflammation of eyelid

410

1.37

1.47

1.6

1.3

1.79

1.45

nmol/l

1.06

370

Rosacea

334

1.41

1.47

1.5

1.3

1.66

1.47

nmol/l

0.55

304

Sequelae of injuries, of poisoning and of other consequences of external causes

107

858

1.25

1.46

1.6

1.3

1.25

1.47

nmol/l

1.59

770

Ulcerative colitis (strict definition, require KELA)

549

1.31

1.46

1.4

1.3

1.46

1.44

nmol/l

0.03

489

Gonarthrosis, primary, with knee surgery

258

1783

1.15

1.44

1.4

1.3

1.63

1.39

nmol/l

2.88

233

1607

Polypectomy (DHB20)

228

1.50

1.44

1.4

1.3

1.44

1.39

nmol/l

0.09

209

Volvulus

1.98

1.43

1.3

1.2

1.22

1.42

nmol/l

0.29

Congenital malformations, deformations and chromosomal abnormalities

259

2149

1.15

1.41

1.3

1.4

1.53

1.42

nmol/l

0.91

235

1936

Skin changes due to chronic exposure to nonionizing radiation

153

1178

1.20

1.41

1.3

1.2

1.45

nmol/l

0.00

131

1067

L01XX Other antineoplastic agents

179

0.50

1.39

1.3

1.2

1.35

1.39

nmol/l

—

159

Intentional self-harm by sharp object

2.01

1.38

1.2

1.3

1.56

1.38

nmol/l

0.18

Non-small cell lung cancer, adenocarcinoma

198

0.50

1.38

1.2

0.96

1.45

nmol/l

—

172

Secondary right heart disease

104

1.74

1.37

1.4

1.2

1.77

1.42

nmol/l

0.55

Neuromuscular dysfunction of bladder

289

1.42

1.36

1.2

1.3

1.10

1.52

nmol/l

1.93

262

Noninflammatory disorders of female genital tract

152

634

1.20

1.35

1.5

1.3

1.58

1.39

nmol/l

1.15

137

571

Inguinal hernia

229

1765

0.87

1.35

1.4

1.3

1.30

1.41

nmol/l

1.00

199

1596

Donors of organs and tissues

0.00

1.35

0.0

1.1

—

1.25

—

Obstructed labour due to maternal pelvic abnormality

409

1.35

1.34

1.5

1.4

1.69

1.52

nmol/l

0.51

372

Endometriosis

126

605

1.22

1.34

1.4

1.66

1.40

nmol/l

1.64

111

544

Diseases of middle ear and mastoid

246

1753

1.15

1.33

1.3

1.51

1.44

nmol/l

0.42

212

1582

120

1.67

1.32

1.3

1.19

1.43

nmol/l

0.42

106

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

602

1.28

1.32

1.4

1.3

1.43

1.45

nmol/l

0.07

538

Phlebitis and thrombophlebitis (not including DVT)

789

1.24

1.32

1.4

1.3

1.52

1.46

nmol/l

0.16

711

Seborrhoeic keratosis

701

1.26

1.30

1.2

1.3

1.50

1.45

nmol/l

0.16

630

Other menopausal disorders

471

0.76

1.30

1.7

1.3

1.37

1.38

nmol/l

0.02

421

Other and unspecified disorders of vitreous body

174

1463

1.17

1.29

1.4

1.3

1.64

1.43

nmol/l

1.56

160

1316

Other abnormal uterine and vaginal bleeding

468

1.27

1.29

1.5

1.3

1.62

1.39

nmol/l

1.00

421

Agranulocytosis

335

1.38

1.28

1.2

1.3

1.55

1.52

nmol/l

0.06

303

Injury of nerves and spinal cord at neck level

1.95

1.28

1.3

1.2

0.73

1.56

nmol/l

2.78

Caries of enamel

417

2713

1.11

1.28

1.5

1.3

1.31

1.45

nmol/l

2.07

375

2459

Other hearing loss

108

863

1.23

1.28

1.3

1.51

1.44

nmol/l

0.27

777

Injuries to the neck

775

1.24

1.27

1.5

1.3

1.33

1.46

nmol/l

0.44

697

Open wound of wrist and hand

212

1798

1.15

1.26

1.4

1.3

1.41

1.42

nmol/l

0.05

193

1624

Crohn disease

406

1.33

1.24

1.6

1.3

1.54

1.43

nmol/l

0.32

363

Guillain-Barre syndrome

2.02

1.23

1.4

1.2

0.90

1.50

nmol/l

—

Traumatic subarachnoid haemorrhage

1.77

1.23

1.5

1.2

0.98

1.40

nmol/l

1.00

Sensorineural hearing loss

356

2167

1.12

1.22

1.3

1.45

1.43

nmol/l

0.13

319

1959

Other and unspecified rosacea

254

1.42

1.21

1.5

1.3

1.72

1.44

nmol/l

0.63

233

Superficial injury of shoulder and upper arm

356

1.35

1.21

1.3

1.94

1.46

nmol/l

1.42

320

Follicular cysts of skin and subcutaneous tissue

629

1.26

1.20

1.3

1.59

1.44

nmol/l

0.53

567

Benign neoplasm: Colon, unspecified

107

881

1.22

1.20

1.3

1.41

1.46

nmol/l

0.17

789

Dementia

165

970

1.17

1.2

1.3

1.19

1.48

nmol/l

3.98

152

873

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

121

1011

1.20

1.17

1.3

1.44

1.46

nmol/l

0.08

113

912

Single delivery by caesarean section

298

1.29

1.16

1.7

1.3

1.56

1.44

nmol/l

0.37

261

Perforation of tympanic membrane

299

1.37

1.16

1.4

1.3

1.64

1.48

nmol/l

0.41

272

Acute poliomyelitis

0.00

1.15

0.0

1.2

—

1.50

—

Long labour

540

1.25

1.15

1.2

1.5

1.35

1.52

nmol/l

0.92

487

Other malignant neoplasms of skin (=non-melanoma skin cancer)

156

1250

0.85

1.15

1.3

1.41

1.44

nmol/l

0.15

140

1133

Stenosis and insufficiency of lacrimal passages

272

0.62

1.14

1.2

1.3

1.31

1.47

nmol/l

0.39

247

Orchitis and epididymitis

334

1.35

1.14

1.3

1.2

1.32

1.40

nmol/l

0.24

299

Other strabismus

676

1.24

1.14

1.3

1.4

1.54

1.43

nmol/l

0.43

612

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

220

1878

1.14

1.13

1.3

1.45

nmol/l

0.03

194

1700

Procreative management

991

0.82

1.13

1.4

1.3

1.38

1.43

nmol/l

0.18

889

Personal history of allergy to drugs, medicaments and biological substances

2.35

1.12

1.1

1.30

1.50

nmol/l

—

Disorders of breast

173

1356

1.16

1.12

1.5

1.4

1.61

1.48

nmol/l

0.81

158

1225

Malignant neoplasm of ovary

113

0.44

1.12

1.8

1.4

1.49

1.37

nmol/l

—

100

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

2.35

1.12

1.3

1.2

1.58

1.53

nmol/l

—

Other pulmonary heart/vessel disease

119

1.60

1.11

1.4

1.2

1.98

1.42

nmol/l

0.86

102

Pyoderma

1.97

1.11

1.6

1.1

1.08

1.43

nmol/l

—

Complications predominantly related to the puerperium

753

1.22

1.11

1.2

1.5

1.68

1.48

nmol/l

0.84

682

Basal cell carcinoma, including avohilmo

158

1266

0.86

1.11

1.3

1.37

1.43

nmol/l

0.34

140

1148

Other extrapyramidal and movement disorders in other diseases

808

1.21

1.10

1.5

1.3

1.47

nmol/l

0.00

722

Other spirochaetal diseases

1096

0.82

1.10

1.4

1.3

1.26

1.47

nmol/l

1.33

982

Nonsuppurative otitis media

573

1.24

1.10

1.3

1.4

1.48

1.41

nmol/l

0.24

523

Effects of foreign body entering through natural orifice

111

927

1.20

1.10

1.4

1.3

1.56

1.42

nmol/l

0.82

102

833

Other benign neoplasms of uterus

136

0.51

1.09

1.6

1.2

1.25

1.48

nmol/l

—

119

Pregnancy, childbirth and the puerperium

404

1.23

1.09

1.5

1.3

1.38

1.52

nmol/l

0.59

358

Subjective visual disturbances

101

836

1.21

1.09

1.3

1.45

1.48

nmol/l

0.09

752

Dermatitis due to ingested food

1.89

1.09

1.6

1.4

0.82

1.17

nmol/l

0.91

Car occupant injured in noncollision transport accident

104

1.64

1.09

1.4

0.94

1.53

nmol/l

2.16

Use of rivastigmine

388

1.31

1.09

1.2

1.12

1.44

nmol/l

2.00

342

Other obstructive and reflux uropathy

104

1.64

1.09

1.5

1.4

2.03

1.53

nmol/l

0.76

Internal derangement of knee

167

1437

1.16

1.09

1.5

1.3

1.45

1.36

nmol/l

0.53

148

1307

Raynaud syndrome

256

0.62

1.09

1.6

1.4

1.83

1.49

nmol/l

0.42

230

Non-small cell lung cancer, adenocarcinoma, helper endpoint

181

0.55

1.08

1.2

0.96

1.50

nmol/l

—

158

Postpartum care and examination

212

1.35

1.07

1.4

1.62

1.49

nmol/l

0.34

187

Other renal tubulo-interstitial diseases

1.93

1.06

1.1

1.4

1.85

1.55

nmol/l

—

Allergic conjunctivitis

231

1994

1.13

1.06

1.4

1.3

1.44

1.46

nmol/l

0.09

204

1803

Other benign neoplasms of skin

150

1292

1.16

1.04

1.3

1.48

1.44

nmol/l

0.23

136

1158

severe traumatic brain injury, does not include concussion

759

1.21

1.04

1.3

1.39

1.45

nmol/l

0.21

682

Pleural plaque without asbestos

1.67

1.04

1.7

1.1

1.24

1.57

nmol/l

0.65

Benign neoplasm: Descending colon

229

1.40

1.03

1.8

1.3

1.52

1.46

nmol/l

0.11

203

Pediculosis, acariasis and other infestations

508

1.26

1.03

1.4

1.3

1.36

1.41

nmol/l

0.13

455

Other spirochaetal diseases

1108

0.83

1.02

1.3

1.31

1.47

nmol/l

0.81

992

Leisure time condition

581

1.24

1.01

1.5

1.3

1.74

1.46

nmol/l

1.28

523

Disorders of globe

1.77

1.00

1.0

1.2

1.70

1.42

nmol/l

0.38

Dentofacial anomalies [including malocclusion]

252

2261

0.89

1.00

1.4

1.3

1.58

1.44

nmol/l

1.30

232

2038

Anogenital herpesviral [herpes simplex] infection

273

1.36

1.00

1.5

1.50

1.49

nmol/l

0.03

247

Any death

243

1949

0.89

1.00

1.2

1.3

1.47

1.42

nmol/l

0.28

215

1772

Lyme disease

1083

0.83

1.00

1.4

1.3

1.26

1.47

nmol/l

1.31

971

Excessive attrition of teeth

246

2199

1.12

1.00

1.4

1.3

1.39

1.43

nmol/l

0.22

226

1980

Scabies

413

1.29

0.99

1.5

1.3

1.34

1.39

nmol/l

0.12

373

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

190

1708

0.88

0.99

1.5

1.3

1.46

1.49

nmol/l

0.12

174

1538

Other disorders of conjunctiva

458

1.27

0.99

1.2

1.3

1.72

1.47

nmol/l

0.69

409

Other interstitial pulmonary diseases

503

1.25

0.98

1.3

1.62

1.46

nmol/l

0.49

442

Interstitial lung disease endpoints

503

1.25

0.98

1.3

1.62

1.45

nmol/l

0.53

442

Interstitial lung disease

503

1.25

0.98

1.3

1.62

1.45

nmol/l

0.53

442

Carcinoma in situ of skin, other sites/unspecified

0.00

0.96

0.0

1.1

—

1.83

—

Nontoxic multinodular goitre

531

1.24

0.96

1.3

1.31

1.42

nmol/l

0.36

488

Seropositive rheumatoid arthritis, wide

102

858

1.19

0.96

1.3

1.64

1.43

nmol/l

1.03

767

Non-allergic asthma

258

1.36

0.96

1.5

1.3

1.47

1.43

nmol/l

0.09

234

Spirochaetal infections, other/unspecified

1088

0.84

0.96

1.4

1.3

1.26

1.47

nmol/l

1.27

976

Basal cell carcinoma

150

1195

0.87

0.96

1.3

1.35

1.44

nmol/l

0.43

135

1083

Abnormal serum enzyme levels

140

1179

1.16

0.95

1.4

1.3

1.37

1.43

nmol/l

0.31

128

1066

Dislocation, sprain and strain of joints and ligaments of knee

269

2234

1.11

0.94

1.3

1.49

1.44

nmol/l

0.35

242

2023

ILD, hospital admissions

497

1.25

0.94

1.3

1.59

1.46

nmol/l

0.36

438

Blepharochalasis

114

971

1.18

0.94

1.4

1.3

1.35

1.46

nmol/l

0.52

108

873

Adjustment and management of implanted device

560

1.23

0.94

1.4

1.3

1.40

1.43

nmol/l

0.09

495

Dementia in other diseases classified elsewhere

117

0.51

0.94

1.0

1.2

0.96

1.42

nmol/l

—

Other hammer toe(s) (acquired)

483

0.76

0.94

1.5

1.3

1.36

1.39

nmol/l

0.06

442

Family history of certain disabilities and chronic diseases leading to disablement

117

0.51

0.94

1.3

1.2

1.22

1.43

nmol/l

—

107

Fissure and fistula of anal and rectal regions

102

861

1.19

0.93

1.3

1.53

1.42

nmol/l

0.49

762

Iridocyclitis in diseases classified elsewhere

1.74

0.92

1.1

1.53

1.44

nmol/l

—

Localized scleroderma [morphea]

2.16

0.91

1.2

1.12

1.44

nmol/l

—

Amiodarone users

357

1.29

0.91

1.3

1.2

1.94

1.49

nmol/l

1.15

316

Sequelae of injuries of neck and trunk

1.60

0.90

2.1

1.2

1.24

1.48

nmol/l

0.39

Carrier of infectious disease

1.75

0.90

1.2

1.35

1.45

nmol/l

0.11

Spondylopathies (FG)

438

1.26

0.89

1.3

1.65

1.39

nmol/l

0.95

397

Anogenital herpesviral [herpes simplex] infection

160

1.44

0.88

1.7

1.3

1.58

1.51

nmol/l

0.10

148

Other/unspecified seropositive rheumatoid arthritis

100

848

1.18

0.88

1.3

1.64

1.44

nmol/l

0.98

761

Abdominal aortic aneurysm (AAA)

243

1.35

0.88

1.1

1.2

1.67

1.39

nmol/l

0.69

207

Solid cancers, helper endpoint

404

2195

1.09

0.88

1.3

1.47

1.44

nmol/l

0.14

361

1984

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.87

0.87

2.1

1.4

1.21

1.26

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

840

1.18

0.87

1.4

1.3

1.62

1.45

nmol/l

0.78

755

Intentional self-harm by unspecified means

2.01

0.87

1.5

1.3

1.30

1.40

nmol/l

—

Respiratory insufficiency

228

1.36

0.87

1.4

1.2

1.55

1.49

nmol/l

0.11

202

Other misadventures during surgical and medical care

1.73

0.86

1.3

1.2

1.20

1.67

nmol/l

0.68

Alzheimer’s disease (Late onset), excluding more controls

240

1.28

0.86

1.2

1.05

1.43

nmol/l

2.89

215

Delivery, wide proxy

109

492

1.18

0.86

1.4

1.3

1.47

1.51

nmol/l

0.13

100

432

Other localized connective tissue disorders

1.83

0.86

1.1

1.2

0.94

1.31

nmol/l

—

Exclusion endpoint for clefts

1.82

0.86

1.3

1.2

2.13

1.39

nmol/l

—

Impacted cerumen

300

1.30

0.84

1.2

1.3

1.43

1.47

nmol/l

0.09

270

Congenital malformations, deformations and chromosomal abnormalities

278

2331

1.10

0.83

1.4

1.3

1.56

1.42

nmol/l

1.32

253

2104

Evidence of alcohol involvement determined by blood alcohol level

1.75

0.82

1.1

1.2

1.24

1.36

nmol/l

—

Medicines for HER+ breast cancer

1055

0.85

0.82

1.5

1.3

1.55

1.50

nmol/l

0.18

946

Pollen allergy

518

1.22

0.82

1.4

1.47

1.36

nmol/l

0.31

467

Contact with machinery

417

1.25

0.82

1.2

1.3

1.45

1.42

nmol/l

0.09

373

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.61

0.81

1.5

1.2

1.25

1.56

nmol/l

0.53

5-aminosalicylic acid

699

1.19

0.81

1.3

1.41

1.38

nmol/l

0.08

617

Tinnitus

839

1.17

0.80

1.5

1.3

1.57

1.43

nmol/l

0.59

753

Benign neoplasm: Liver/bile ducts

1.67

0.79

1.1

1.4

1.67

1.57

nmol/l

0.09

Haemorrhoids and perianal venous thrombosis

127

1108

1.14

0.78

1.4

1.3

1.51

1.39

nmol/l

0.59

113

998

Benign neoplasm: Skin of eyelid, including canthus

501

1.22

0.78

1.2

1.3

1.42

1.50

nmol/l

0.27

452

Diseases of inner ear

225

1969

1.11

0.78

1.4

1.3

1.49

1.43

nmol/l

0.38

204

1775

Other specified disorders of kidney and ureter

1.56

0.78

1.4

1.3

2.29

1.58

nmol/l

1.00

Injury of other and unspecified intrathoracic organs

199

1.36

0.78

1.1

1.2

1.21

1.39

nmol/l

0.46

180

Budesonide

402

1.25

0.78

1.3

1.48

1.38

nmol/l

0.25

353

Artificial joint operation, meniscal resection

431

2601

1.08

0.77

1.4

1.3

1.57

1.41

nmol/l

2.21

392

2344

Focal epilepsy

703

1.18

0.77

1.5

1.3

1.58

1.46

nmol/l

0.39

629

Left bundle-branch block

217

1.34

0.76

1.5

1.3

1.58

1.40

nmol/l

0.46

192

Lichen planus

385

1.25

0.76

1.2

1.3

1.47

1.46

nmol/l

0.02

347

Other disorders of veins

160

1415

1.13

0.76

1.3

1.46

1.43

nmol/l

0.10

148

1271

Pleural plaque with presence of asbestos

233

0.68

0.76

1.7

1.2

1.48

1.53

nmol/l

0.11

205

Carcinoma in situ, bladder

1.54

0.75

1.3

1.2

1.23

1.54

nmol/l

0.63

Benign neoplasm: other/unspecified salivary gland

1.65

0.75

1.1

1.2

2.24

1.55

nmol/l

0.95

Burn and corrosion of trunk

1.57

0.75

1.2

1.39

1.43

nmol/l

0.06

Muscle strain

1.57

0.75

1.5

1.2

1.31

1.34

nmol/l

0.04

Malignant neoplasm of breast, ER-negative, including Hilmo

585

0.81

0.74

1.5

1.3

1.54

1.44

nmol/l

0.23

525

Measles

1.86

0.74

1.1

1.8

1.23

1.42

nmol/l

—

Disorders of synovium and tendon in diseases classified elsewhere

1.64

0.73

1.1

1.23

1.39

nmol/l

—

Any dementia, excluding more controls

124

747

1.14

0.73

1.2

1.16

1.42

nmol/l

2.67

113

666

Later onset COPD

740

0.85

0.73

1.1

1.2

1.79

1.41

nmol/l

1.64

663

Obstructive hydrocephalus

1.80

0.72

1.1

1.50

1.56

nmol/l

—

Panhypopituitarism

1.62

0.72

1.2

1.1

1.99

1.64

nmol/l

—

Immunodeficiencies

142

1.41

0.72

1.1

1.4

1.81

1.40

nmol/l

0.58

128

Fourth [trochlear] nerve palsy

1.59

0.71

1.1

1.14

1.54

nmol/l

—

Other and unspecified vasculitis limited to skin

1.58

0.71

1.3

1.1

1.31

1.51

nmol/l

—

Osteoporosis

732

1.16

0.71

1.3

1.43

1.42

nmol/l

0.01

665

Hallux valgus (acquired)

813

0.87

0.71

1.4

1.3

1.32

1.43

nmol/l

0.49

734

Infectious mononucleosis

194

1.34

0.71

1.4

1.2

1.53

1.47

nmol/l

0.09

179

Degenerative macular diseases

327

1.26

0.70

1.2

1.3

1.49

1.55

nmol/l

0.13

291

Primary coxarthrosis, bilateral

110

963

1.14

0.69

1.4

1.2

1.69

1.41

nmol/l

1.73

101

869

Focal epilepsy, mode (most common among epilepsy diagnosis)

619

1.18

0.69

1.5

1.3

1.52

1.46

nmol/l

0.18

555

Alzheimer disease, including avohilmo

122

756

1.14

0.68

1.2

1.08

1.47

nmol/l

6.41

109

687

Previous suicide attempt

1.86

0.68

1.4

1.84

1.35

nmol/l

—

Blood alcohol or alcohol intoxication level

1.60

0.68

1.1

1.4

1.27

1.29

nmol/l

0.03

Secondary parkinsonism

1.60

0.68

1.2

1.63

1.45

nmol/l

0.19

Contraceptive management

151

1184

0.89

0.68

1.7

1.4

1.53

1.42

nmol/l

0.68

139

1067

Wide developmental disorders

1.59

0.68

1.4

1.3

1.76

1.21

nmol/l

1.39

Other congenital malformations of skin

102

1.48

0.67

1.7

1.4

1.48

1.38

nmol/l

0.15

Crohn disease (strict definition, all UC cases excluded)

153

1.38

0.67

1.4

1.76

1.44

nmol/l

0.76

140

Use of amantadine

1.63

0.67

1.3

1.1

1.42

nmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

705

1.16

0.67

1.6

1.2

1.60

1.44

nmol/l

0.63

642

Congenital ovarian cysts

0.53

0.66

1.2

1.5

1.74

1.50

nmol/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

496

1.19

0.65

1.2

1.3

1.54

1.45

nmol/l

0.23

451

Chorioretinal inflammation

1.58

0.65

1.3

1.5

2.01

1.46

nmol/l

0.88

Benign neoplasm: Liver

1.62

0.65

1.1

1.5

1.41

1.51

nmol/l

—

Carcinoma in situ of other and unspecified sites

103

1.46

0.65

1.3

1.2

1.20

1.48

nmol/l

0.62

Secondary and unspecified malignant neoplasm of lymph nodes

286

1.26

0.65

1.3

1.20

1.44

nmol/l

0.92

253

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

177

1326

0.90

0.65

1.3

1.40

1.43

nmol/l

0.15

159

1202

Seropositive rheumatoid arthritis, strict definition

459

1.20

0.64

1.3

1.83

1.50

nmol/l

1.04

418

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

234

2089

1.09

0.63

1.3

1.45

1.42

nmol/l

0.14

213

1890

Other puerperal infections

172

1.34

0.63

1.4

1.6

1.91

1.54

nmol/l

0.59

157

Deviated nasal septum

152

1367

1.11

0.63

1.3

1.48

1.42

nmol/l

0.25

136

1242

Occupational exposure to risk-factors

103

0.58

0.62

1.3

1.2

0.85

1.49

nmol/l

—

Alzheimer’s disease (Early onset)

102

0.59

0.62

1.2

1.03

1.53

nmol/l

—

Other sexually transmitted chlamydial diseases

234

0.73

0.62

2.0

1.4

0.59

1.46

nmol/l

5.40

212

Viral pneumonia (known virus, not influenza)

1.59

0.62

1.7

1.2

1.25

1.60

nmol/l

—

Carcinoma in situ of other and unspecified digestive organs

1.46

0.61

1.4

1.2

1.36

1.47

nmol/l

0.15

Other bursitis of hip

1.57

0.60

1.1

1.43

1.38

nmol/l

—

Autism spe

1.57

0.60

1.1

1.4

1.79

1.22

nmol/l

—

Carcinoma in situ of breast, intraductal

209

1.29

0.60

1.2

1.4

1.59

1.46

nmol/l

0.26

189

Pneumocystosis

1.54

0.59

1.1

1.2

1.22

1.64

nmol/l

—

Intussusception

1.54

0.59

1.0

1.2

1.71

1.25

nmol/l

—

Abnormal findings on diagnostic imaging of lung

204

1794

1.09

0.59

1.2

1.3

1.46

1.41

nmol/l

0.32

185

1626

Malignant neoplasm of corpus uteri

201

1.30

0.58

1.3

1.99

1.42

nmol/l

1.65

176

Allergic contact dermatitis

372

1.21

0.58

1.3

1.4

1.35

1.38

nmol/l

0.05

334

Vasculitis limited to skin, not elsewhere classified

1.57

0.58

1.3

1.1

1.30

1.53

nmol/l

—

ILD, hospital admissions 1, main diag only

455

1.19

0.58

1.3

1.51

1.48

nmol/l

0.07

404

Deep bite

272

0.77

0.58

1.4

1.60

1.38

nmol/l

0.46

250

Contusion of toe(s) with damage to nail

1.72

0.58

1.3

1.1

0.90

1.46

nmol/l

—

Ménière disease

287

0.77

0.57

1.4

1.3

1.40

1.48

nmol/l

0.15

259

Fracture of femur

760

1.13

0.56

1.3

1.35

1.45

nmol/l

0.35

684

Other diseases of spinal cord

0.58

0.56

1.4

1.2

0.62

1.38

nmol/l

—

Serous carcinoma of ovary, including Hilmo

0.58

0.56

1.4

1.5

2.02

1.34

nmol/l

—

Secondary parkinsonism+Parkinsonism in other disease

1.51

0.56

1.2

1.1

1.63

1.39

nmol/l

0.28

Major anomalies of jaw size

1.51

0.56

1.4

1.5

1.78

1.50

nmol/l

0.38

therapeutic use

0.57

0.56

1.2

1.63

1.43

nmol/l

—

Allergic purpura

0.57

0.56

1.2

1.4

1.44

1.41

nmol/l

—

Bitten or struck by other mammals

329

1.22

0.55

1.8

1.3

1.33

1.48

nmol/l

0.43

295

Colectomy operation

560

1.16

0.55

1.3

1.17

1.50

nmol/l

2.03

493

Retinal detachment with retinal break

412

1.19

0.55

1.3

1.60

1.58

nmol/l

0.04

374

Lichen ruber planus, wide definition including periferal and oral lichen planus

738

1.14

0.54

1.2

1.3

1.59

1.48

nmol/l

0.36

669

Extrapyramidal and movement disorders

147

1335

1.10

0.54

1.4

1.3

1.57

1.42

nmol/l

0.94

133

1200

Exposure to smoke, fire and flames

1.47

0.54

1.5

1.2

1.87

1.44

nmol/l

0.65

Peroneal tendinitis

1.58

0.54

1.2

1.1

0.99

1.48

nmol/l

—

Autoimmune thyroiditis

1.58

0.54

1.5

1.3

0.98

1.31

nmol/l

—

Peritonsillar abscess

758

1.14

0.53

1.6

1.4

1.43

1.47

nmol/l

0.11

683

Temporomandibular joint disorders, including avohilmo

138

1497

0.91

0.52

1.5

1.4

1.60

1.46

nmol/l

0.71

128

1346

Lichen planus, including avohilmo

619

1.15

0.52

1.2

1.3

1.53

1.50

nmol/l

0.10

563

L02BG Aromatase inhibitors

863

0.88

0.51

1.5

1.3

1.46

1.47

nmol/l

0.04

775

Paraplegia, diplegia of upper limbs

1.41

0.51

1.1

1.15

1.59

nmol/l

—

Melanocytic naevi of upper limb, including shoulder

1.41

0.51

1.7

1.5

1.33

1.41

nmol/l

—

Purpura and other haemorrhagic conditions

443

1.18

0.51

1.3

1.64

1.50

nmol/l

0.37

399

Bacterial, viral and other infectious agents

296

1.22

0.51

1.4

1.3

1.44

nmol/l

0.00

268

Varicose veins

250

1758

1.07

0.51

1.3

1.57

1.41

nmol/l

1.35

223

1588

Malignant neoplasm of skin

187

1390

0.92

0.51

1.3

1.44

nmol/l

0.00

166

1257

Unspecified haematuria

180

1373

1.09

0.51

1.2

1.3

1.47

1.40

nmol/l

0.32

157

1243

Bacterial, viral and other infectious agents

315

1.21

0.50

1.4

1.3

1.47

1.43

nmol/l

0.10

286

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

539

1.15

0.50

1.2

1.3

1.61

1.45

nmol/l

0.49

490

Malignant neoplasm of breast, including Hilmo

123

880

0.90

0.50

1.5

1.3

1.53

1.48

nmol/l

0.21

111

792

Malignant neoplasm of breast, HER2-negative, including Hilmo

123

880

0.90

0.50

1.5

1.3

1.53

1.48

nmol/l

0.21

111

792

COPD, hospital admissions 3, with asthma pneumonia sepsis

105

805

1.11

0.49

1.5

1.2

1.60

1.41

nmol/l

0.87

724

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.43

0.49

1.0

1.2

2.04

1.41

nmol/l

1.53

Divergent concomitant strabismus

216

1.25

0.49

1.5

1.3

1.34

1.45

nmol/l

0.17

194

Unspecified urinary incontinence

246

0.77

0.49

1.5

1.3

1.31

1.54

nmol/l

0.39

220

Atrophic disorders of skin

390

1.18

0.49

1.4

1.42

1.47

nmol/l

0.12

349

Generalized epilepsy

119

1.35

0.48

1.0

1.4

1.94

1.44

nmol/l

1.48

110

Tonsillectomy and adenotomy

229

1484

1.07

0.48

1.5

1.4

1.45

nmol/l

0.01

208

1337

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.49

0.47

1.3

1.1

1.14

1.29

nmol/l

—

Contact with heat and hot substances

146

1.30

0.47

1.3

1.5

1.22

1.41

nmol/l

0.63

133

Malnutrition

1.46

0.47

1.3

1.1

1.14

1.48

nmol/l

—

Papillary adenocarcinoma of thyroid gland

153

0.72

0.45

1.2

1.4

1.48

1.42

nmol/l

0.07

136

Congenital malformations of ovaries, fallopian tubes and broad ligaments

120

0.67

0.45

1.1

1.5

1.70

1.46

nmol/l

—

108

Impetigo

103

1.36

0.45

1.2

1.4

1.03

1.42

nmol/l

1.53

Thyrotoxicosis with diffuse goitre

366

1.18

0.44

1.2

1.4

1.33

1.48

nmol/l

0.29

331

Fracture at wrist and hand level

142

1302

1.09

0.44

1.4

1.3

1.32

1.42

nmol/l

0.53

125

1170

Hereditary corneal dystrophies

1.40

0.44

1.6

1.3

1.67

1.34

nmol/l

0.48

Meningitis

139

1.30

0.43

1.3

1.4

1.16

1.49

nmol/l

1.00

124

Osteonecrosis

202

1.24

0.43

1.8

1.2

1.52

1.41

nmol/l

0.16

181

Benign neoplasm: Oesophagus

1.62

0.43

1.0

1.1

1.21

1.80

nmol/l

—

Any event in cancer register

436

2448

1.05

0.43

1.3

1.47

1.44

nmol/l

0.25

392

2212

Lung diseases due to external agents

443

1.15

0.42

1.5

1.3

1.33

1.45

nmol/l

0.34

394

6-mercaptopurine

1.38

0.42

1.3

1.02

1.26

nmol/l

0.74

Malignant neoplasm of breast, ER-positive, including Hilmo

761

0.90

0.42

1.5

1.3

1.55

1.47

nmol/l

0.30

682

Malignant neoplasm of breast

122

869

0.92

0.41

1.5

1.3

1.55

1.48

nmol/l

0.32

109

782

Other noninfective disorders of lymphatic vessels and lymph nodes

1.36

0.41

1.1

1.2

1.43

1.41

nmol/l

0.02

Autism

1.38

0.41

1.1

1.4

1.79

1.21

nmol/l

—

Juvenile arthritis (FINNGEN)

1.36

0.41

1.8

1.3

1.20

1.53

nmol/l

0.50

Nontraumatic intracranial haemmorrhage

632

1.12

0.41

1.4

1.3

1.38

1.45

nmol/l

0.22

567

Ulcerative rectosigmoiditis

249

1.21

0.41

1.2

1.3

1.38

1.50

nmol/l

0.34

225

Muscle wasting and atrophy, not elsewhere classified

0.00

0.41

0.0

1.0

—

1.63

—

Inflammation of lacrimal passages (chronic)

1.52

0.41

1.2

1.0

1.36

1.49

nmol/l

—

Secondary uncertain malignant neoplasm

435

1.15

0.41

1.2

1.3

1.24

1.44

nmol/l

0.87

388

Unspecific neurodegenerative disorder

145

915

1.08

0.40

1.2

1.16

1.47

nmol/l

4.99

132

824

Benign neoplasm: Skin of scalp and neck

1.34

0.40

1.5

1.2

1.29

1.38

nmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

156

1448

1.08

0.40

1.4

1.3

1.63

1.41

nmol/l

1.53

139

1310

Primary_lymphoid and hematopoietic malignant neoplasms

824

1.11

0.40

1.4

1.3

1.27

1.47

nmol/l

1.21

738

Colonic or urogenital fistula

107

977

1.10

0.40

1.3

1.48

1.46

nmol/l

0.09

877

Focal epilepsy, strict definition

653

1.12

0.40

1.5

1.3

1.49

1.47

nmol/l

0.04

589

Liquid cancers, helper endpoint

157

1272

1.08

0.39

1.4

1.3

1.39

1.43

nmol/l

0.20

140

1143

Anankastic personality disorder

106

1.32

0.39

1.4

1.5

1.64

1.51

nmol/l

0.19

100

Benign neoplasm of brain and other parts of central nervous system

193

0.78

0.39

1.1

1.3

1.64

1.40

nmol/l

0.39

170

Motorcycle rider injured in other and unspecified transport accidents

178

1.24

0.38

1.3

1.4

1.67

1.38

nmol/l

0.45

166

UC patients in KELA-register (code 208), prior to 1994

133

1.28

0.38

1.2

1.4

1.63

1.50

nmol/l

0.16

121

Speech therapy

915

0.91

0.37

1.2

1.3

1.12

1.48

nmol/l

3.18

821

Other mental disorders due to brain damage and dysfunction and to physical disease

364

1.16

0.37

1.1

1.3

1.57

1.49

nmol/l

0.21

324

Coxarthrosis, primary

247

1978

1.06

0.37

1.4

1.3

1.61

1.41

nmol/l

2.22

220

1800

Intermittent heterotropia

146

0.75

0.36

1.2

1.80

1.40

nmol/l

0.89

133

Use of anticholinesterases

112

813

1.09

0.35

1.2

1.09

1.46

nmol/l

5.49

102

735

N06DA Anticholinesterases

112

813

1.09

0.35

1.2

1.09

1.46

nmol/l

5.49

102

735

Intracerebral haemorrhage

366

1.15

0.35

1.3

1.2

1.58

1.46

nmol/l

0.29

330

Cerebral aneurysm, nonruptured

273

1.17

0.35

1.6

1.4

1.35

1.46

nmol/l

0.25

247

Alzheimer disease

650

1.09

0.35

1.2

1.11

1.48

nmol/l

4.80

588

Other and unspecified diseases of blood and blood-forming organs

1.37

0.34

1.3

1.1

1.25

1.55

nmol/l

—

Sulfasalazine

108

997

1.08

0.34

1.4

1.3

1.43

1.41

nmol/l

0.07

883

Non-follicular lymphoma

329

0.85

0.33

1.3

1.32

1.50

nmol/l

0.53

294

Malignant neoplasm of breast, HER-negative

531

0.89

0.33

1.5

1.3

1.59

1.42

nmol/l

0.45

480

Glaucoma-related operations

155

0.77

0.33

1.1

1.2

1.38

1.47

nmol/l

0.10

136

Malignant neoplasm of breast, HER-positive

756

0.92

0.32

1.5

1.3

1.55

1.47

nmol/l

0.29

677

Acute epiglottitis

1.28

0.32

1.3

1.1

1.52

1.49

nmol/l

—

Degenerative diseases of the nervous system

118

805

1.08

0.32

1.2

1.12

1.46

nmol/l

4.42

106

729

Postprocedural disorders of nervous system

183

1.20

0.31

1.6

1.5

1.35

1.49

nmol/l

0.28

168

Rheumatic valve diseases

1.35

0.31

1.3

1.1

1.15

1.61

nmol/l

—

Other and unspecified hydrocephalus

1.32

0.31

1.3

1.2

1.66

1.56

nmol/l

—

Use of ropinirole

0.71

0.31

1.1

1.2

1.99

1.50

nmol/l

—

Malignant neoplasm of breast, HER2-negative

122

856

0.93

0.30

1.5

1.3

1.55

1.48

nmol/l

0.29

109

770

Triptan medication for migraine, single purchase ok

301

2128

0.96

0.30

1.4

1.3

1.55

1.45

nmol/l

0.83

275

1914

Migraine, single triptan purchase ok & required. ICD-code if available is included

301

2128

0.96

0.30

1.4

1.3

1.55

1.45

nmol/l

0.83

275

1914

Assault by sharp object

1.28

0.30

1.4

1.2

0.76

1.33

nmol/l

—

Hyperplasia of prostate

182

976

1.06

0.30

1.3

1.40

nmol/l

0.04

160

886

Presence of other devices

732

1.09

0.29

1.2

1.48

1.39

nmol/l

0.37

656

Embedded teeth, including avohilmo

222

1.17

0.29

1.3

1.4

1.21

1.43

nmol/l

0.71

206

Hypoplasia of dental enamel , including avohilmo

1.24

0.29

1.1

1.3

1.46

1.19

nmol/l

—

Other abnormal products of conception

588

1.08

0.29

1.4

1.33

1.55

nmol/l

1.13

530

Congenital malformations of genital organs

215

0.83

0.28

1.3

1.4

1.64

1.45

nmol/l

0.33

192

Use of other anti-dementia drugs

626

1.09

0.28

1.2

1.16

1.46

nmol/l

3.07

563

Use of memantine

626

1.09

0.28

1.2

1.16

1.46

nmol/l

3.07

563

Benign lipomatous neoplasm

114

1066

1.07

0.28

1.2

1.3

1.66

1.45

nmol/l

1.31

108

953

Benign neoplasm of thyroid gland

1.28

0.28

1.2

1.4

1.36

1.35

nmol/l

0.01

LSIL lesion of the vulva

1.27

0.27

2.1

1.5

1.38

nmol/l

—

Female infertility, tubal origin

116

0.77

0.27

1.3

1.58

1.42

nmol/l

—

104

Disturbances of smell and taste

121

0.74

0.27

1.3

1.4

1.35

1.43

nmol/l

—

106

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

528

1.10

0.27

1.2

1.3

1.40

1.45

nmol/l

0.16

476

Alzheimer’s disease, strict definition

550

0.91

0.27

1.2

1.03

1.48

nmol/l

4.56

493

Pedestrian injured in collision with car, pick-up truck or van

1.21

0.26

1.3

1.2

1.17

1.44

nmol/l

—

Malignant melanoma

490

1.10

0.26

1.1

1.3

1.37

1.42

nmol/l

0.14

437

Postprocedural musculoskeletal disorders, not elsewhere classified

215

1.16

0.26

1.4

1.3

1.41

1.56

nmol/l

0.30

192

Malignant neoplasm of thyroid gland

193

0.83

0.26

1.2

1.4

1.43

1.38

nmol/l

0.07

174

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

884

1.07

0.26

1.3

1.51

1.44

nmol/l

0.21

800

Postmenopausal bleeding

440

1.08

0.26

1.5

1.3

1.54

1.39

nmol/l

0.54

399

Contact with sharp object, undetermined intent

1.30

0.26

1.4

1.2

1.25

1.42

nmol/l

—

Other fall from one level to another

790

0.92

0.26

1.4

1.3

1.29

1.46

nmol/l

0.91

710

Graves disease, strict definition

272

1.14

0.26

1.2

1.4

1.19

1.47

nmol/l

0.86

244

Atopic dermatitis

227

1780

1.05

0.25

1.4

1.3

1.47

1.42

nmol/l

0.24

211

1606

Later onset COPD, excluding more controls

535

1.08

0.25

1.1

1.2

1.81

1.39

nmol/l

1.73

489

Any dementia

130

851

1.06

0.25

1.2

1.15

1.46

nmol/l

3.75

119

766

Other sexually transmitted chlamydial diseases

148

0.81

0.24

2.2

1.4

0.63

1.44

nmol/l

3.18

135

Erythema nodosum

1.28

0.24

1.4

1.3

1.93

1.51

nmol/l

—

Other congenital malformations of face and neck

0.72

0.24

1.2

1.5

1.42

1.33

nmol/l

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.32

0.23

1.2

1.21

1.44

nmol/l

—

Postzoster neuralgia

1.32

0.23

1.2

1.1

1.71

1.58

nmol/l

—

Contact with and exposure to communicable diseases

104

975

1.06

0.22

1.6

1.4

1.42

1.41

nmol/l

0.03

876

Other disorders of optic disc

1.25

0.22

1.4

1.2

0.86

1.63

nmol/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.25

0.22

1.4

2.06

1.46

nmol/l

—

Pedal cyclist injured in transport accident

758

1.07

0.21

1.2

1.3

1.42

1.45

nmol/l

0.09

682

Labour and delivery complicated by fetal stress [distress]

375

1.08

0.21

1.3

1.5

1.64

1.54

nmol/l

0.27

337

Nasal polyp

700

1.07

0.21

1.4

1.3

1.36

1.47

nmol/l

0.49

634

Other abnormalities of plasma proteins

1.19

0.21

1.0

1.1

1.53

1.67

nmol/l

—

Rare circulating lymphoid malignancy

0.00

0.21

0.0

1.2

—

1.84

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

154

1.17

0.21

1.7

1.2

1.61

1.46

nmol/l

0.33

133

Assault by blunt object

1.16

0.21

1.6

1.2

0.92

1.40

nmol/l

—

Hypersensitivity pneumonitis due to organic dust

1.16

0.21

1.6

1.1

0.97

1.65

nmol/l

—

Voice disturbances

884

0.94

0.21

1.6

1.3

1.62

1.48

nmol/l

0.49

783

Malignant neoplasm of thyroid gland, including Hilmo

209

0.86

0.21

1.2

1.4

1.39

1.42

nmol/l

0.04

189

Bicuspidal aortic valve syndrome

123

0.81

0.20

1.1

1.2

1.64

1.43

nmol/l

—

107

Certolizumab pegol

1.25

0.20

1.3

1.25

1.50

nmol/l

—

Other vitreous opacities

112

0.80

0.20

2.0

1.2

1.92

1.46

nmol/l

—

100

Bacterial meningitis

1.21

0.19

1.3

1.4

1.10

1.46

nmol/l

0.71

Laparoscopic left hemicolectomy

1.18

0.19

1.3

1.1

0.84

1.71

nmol/l

—

Congenital malformations of heart and great arteries

382

1.09

0.19

1.2

1.3

1.49

1.42

nmol/l

0.16

346

Small cell lung cancer

1.15

0.19

1.2

1.26

1.51

nmol/l

—

Small cell lung cancer, including Hilmo

1.15

0.19

1.2

1.26

1.51

nmol/l

—

Epiphora

1.13

0.18

1.3

1.2

1.54

1.50

nmol/l

—

Perioral dermatitis

1.13

0.18

2.2

1.5

1.53

1.55

nmol/l

—

Inguinal hernia, bilateral

405

0.91

0.18

1.4

1.2

1.14

1.45

nmol/l

1.55

356

Ethmoidectomy

425

1.08

0.18

1.9

1.3

1.46

1.43

nmol/l

0.07

384

Obstructed labour due to malposition and malpresentation of fetus

559

1.07

0.18

1.6

1.5

1.48

nmol/l

0.01

505

Malignant melanoma, including Hilmo

590

1.07

0.18

1.1

1.3

1.39

1.44

nmol/l

0.16

528

Deep endometriosis

237

0.89

0.17

1.3

1.4

1.42

1.56

nmol/l

0.39

212

Benign neoplasm: Larynx

1.21

0.17

1.0

1.2

1.24

1.55

nmol/l

0.94

Molar incisor enamel hypoplasia

1.14

0.17

1.1

1.3

1.46

1.19

nmol/l

—

Chronic diseases of tonsils and adenoids

347

2137

1.03

0.17

1.4

1.3

1.46

1.43

nmol/l

0.23

315

1935

Malignant neoplasm of endocrine gland

205

0.88

0.17

1.2

1.4

1.45

1.41

nmol/l

0.07

186

Anomalies of pupillary function

1.11

0.17

1.4

1.3

1.82

1.41

nmol/l

—

Burn and corrosion of head and neck

0.73

0.17

1.2

1.66

1.39

nmol/l

—

Colorectal cancer

796

0.95

0.17

1.3

1.27

1.42

nmol/l

0.72

719

Autoimmune hyperthyroidism

129

1.16

0.17

1.1

1.5

1.71

1.56

nmol/l

—

120

Fall involving bed

1.14

0.16

1.0

1.1

2.39

1.59

nmol/l

—

Crushed, pushed or stepped on by crowd or human stampede

204

0.88

0.16

1.2

1.4

1.08

1.38

nmol/l

0.61

186

Melanocytic naevi

106

1013

1.05

0.16

1.6

1.4

1.32

1.47

nmol/l

0.69

909

Endometriosis of rectovaginal septum and vagina

183

0.87

0.16

1.4

1.3

1.51

1.39

nmol/l

0.27

164

Striking against or struck by other objects

129

1238

1.04

0.16

1.5

1.3

1.57

1.42

nmol/l

0.78

114

1119

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.09

0.15

1.3

1.34

1.25

nmol/l

—

Carcinoma in situ of skin of trunk

0.78

0.15

1.2

1.1

1.44

1.48

nmol/l

—

Tooth agenesis EXCLUDE clefts and syndromes

0.77

0.15

1.0

1.5

1.72

1.40

nmol/l

—

Benign neoplasm: Tongue

0.76

0.15

1.3

1.2

1.22

1.43

nmol/l

—

Monoarthritis, not elsewhere classified

121

1.16

0.15

1.1

1.2

2.05

1.58

nmol/l

0.67

113

Rare circulating lymphoid malignancy, including Hilmo

1.11

0.15

1.2

1.21

1.40

nmol/l

—

Delivery

129

654

1.04

0.15

1.4

1.3

1.56

1.48

nmol/l

0.35

118

579

FESS (DNB20)

410

1.07

0.15

1.9

1.3

1.38

1.43

nmol/l

0.13

371

Foreign body on external eye

566

1.06

0.14

1.4

1.3

1.50

1.44

nmol/l

0.21

511

Other and unspecified intracranial injuries

0.80

0.14

1.6

1.1

1.65

1.33

nmol/l

—

Contact with other hot fluids

0.79

0.14

1.3

1.5

1.16

1.37

nmol/l

—

Other congenital malformations of skin

217

1.11

0.14

2.2

1.3

1.58

1.51

nmol/l

0.16

193

COPD, hospital admissions 1, only main diagnosis

119

1059

0.96

0.14

1.3

1.2

1.59

1.42

nmol/l

0.75

106

955

Endometriosis ASRM stages 3,4

635

0.94

0.14

1.3

1.4

1.62

1.49

nmol/l

0.36

569

Contact with sharp glass

118

0.85

0.14

1.1

1.3

1.03

1.39

nmol/l

—

108

Ankylosing spondylitis, strict definition

139

0.86

0.14

1.1

1.4

1.53

1.40

nmol/l

0.19

129

Atypical facial pain

139

0.86

0.14

1.4

1.2

1.26

1.41

nmol/l

0.28

124

Embedded and impacted teeth

645

1.05

0.14

1.4

1.38

1.39

nmol/l

0.06

587

Burns and corrosions confined to eye and internal organs

1.19

0.14

1.5

1.82

1.37

nmol/l

—

Polyp of the female genital tract

539

1.04

0.13

1.4

1.62

1.39

nmol/l

1.10

484

Fenamates

345

1.06

0.13

1.3

1.2

1.70

1.41

nmol/l

1.00

310

Malignant melanoma of skin, including Hilmo

490

1.06

0.13

1.1

1.3

1.44

1.43

nmol/l

0.03

438

Malignant melanoma of skin

383

1.07

0.13

1.1

1.3

1.46

1.47

nmol/l

0.03

342

Benign mammary dysplasia

356

0.93

0.13

1.5

1.4

1.58

1.44

nmol/l

0.31

320

Brain meningioma

138

0.87

0.13

1.1

1.4

0.95

1.43

nmol/l

1.28

121

Dislocation, sprain and strain of joint and ligaments of hip

107

0.84

0.13

2.1

1.2

1.84

1.44

nmol/l

—

Acute nasopharyngitis (common cold)

439

1.06

0.13

1.4

1.3

1.22

1.43

nmol/l

0.70

402

Injury of eye and orbit

501

1.06

0.12

1.4

1.3

1.60

1.43

nmol/l

0.31

452

Sequelae of injuries of head

171

1.11

0.12

1.5

1.4

0.91

1.47

nmol/l

1.49

157

Separation of retinal layers (serosa)

127

0.87

0.12

1.4

1.2

1.62

1.46

nmol/l

0.30

117

Golimumab

104

1.16

0.12

2.1

1.4

1.87

1.48

nmol/l

0.63

Left ventricular outflow tract obstruction, narrow definition

152

1.12

0.12

1.1

1.3

1.79

1.46

nmol/l

0.56

134

Abnormalities of forces of labour

239

1.09

0.12

1.3

1.5

1.71

1.47

nmol/l

0.44

214

Localized swelling, mass and lump of skin and subcutaneous tissue

109

1127

0.97

0.11

1.3

1.57

1.43

nmol/l

0.60

1007

Impacted teeth

465

1.05

0.11

1.5

1.4

1.41

1.39

nmol/l

0.06

424

Myocardial infarction, with ST-elevation

602

1.05

0.11

1.2

1.23

1.46

nmol/l

1.17

534

Erosion of teeth , including avohilmo

839

1.04

0.10

1.6

1.4

1.22

1.47

nmol/l

1.77

749

Prepatellar bursitis

154

1.10

0.10

1.2

1.3

1.33

1.47

nmol/l

0.23

139

Other and unspecified iridocyclitis

135

1.11

0.09

1.4

1.52

1.43

nmol/l

0.12

121

Congenital malformations of great arteries

1.09

0.09

1.0

1.3

2.02

1.18

nmol/l

—

Glucosamine medication

171

1333

1.02

0.09

1.3

1.57

1.45

nmol/l

0.86

154

1204

Viral infections of central nervous system, not elsewhere classified/unspecified

1.09

0.09

1.2

1.1

1.48

1.28

nmol/l

—

Injuries to the elbow and forearm

281

2428

1.02

0.09

1.4

1.3

1.36

1.44

nmol/l

0.58

254

2191

Cardiodefibrillation

134

1371

0.97

0.09

1.2

1.3

1.60

1.41

nmol/l

1.21

121

1237

Single spontaneous delivery

120

653

0.97

0.09

1.3

1.56

1.48

nmol/l

0.34

109

578

Postmenopausal atrophic vaginitis

448

1.03

0.09

1.1

1.3

1.38

1.40

nmol/l

0.04

406

Melanocytic naevi of scalp and neck

1.07

0.08

2.8

1.2

1.00

1.42

nmol/l

—

Non-Hodgkin lymphoma, all, including Hilmo

451

0.95

0.08

1.3

1.36

1.45

nmol/l

0.25

406

Biological medicines for asthma

1.05

0.08

1.3

1.2

1.43

1.47

nmol/l

—

Allergic contact dermatitis due to drugs in contact with skin

1.05

0.08

1.2

1.5

1.28

1.41

nmol/l

—

Inguinal or femoral hernia, bilateral

410

0.95

0.08

1.3

1.2

1.16

1.45

nmol/l

1.48

361

In situ neoplasms

131

1279

1.02

0.08

1.2

1.3

1.50

1.46

nmol/l

0.15

118

1149

Brain meningioma, including Hilmo

144

0.90

0.08

1.1

1.4

0.95

1.42

nmol/l

1.41

126

Other disorders of binocular movement

0.83

0.08

1.2

1.3

1.32

1.41

nmol/l

—

0.81

0.08

1.2

1.1

1.29

1.45

nmol/l

—

Triptan medication for migraine, min. 3 purchases

199

1547

0.98

0.08

1.4

1.46

1.47

nmol/l

0.03

185

1398

Carcinoma in situ of skin of scalp and neck

0.79

0.08

1.0

1.1

0.65

1.54

nmol/l

—

Antenatal screening

357

1.04

0.08

1.4

1.58

1.46

nmol/l

0.41

317

Unspecified nephritic syndrome

1.09

0.08

1.3

1.2

1.79

1.48

nmol/l

—

Erosion and ectropion of cervix uteri

1.09

0.08

1.4

1.2

1.85

1.59

nmol/l

—

Viral agents as the cause of diseases classified to other chapters

0.86

0.07

1.2

0.93

1.40

nmol/l

—

Injury of muscle and tendon at ankle and foot level

0.84

0.07

1.2

1.3

3.34

1.50

nmol/l

—

Coxarthrosis, primary, with hip surgery

170

1621

0.98

0.07

1.4

1.3

1.58

1.41

nmol/l

1.29

149

1478

Other inflammation of vagina/vulva

1.08

0.07

1.0

1.6

1.47

1.51

nmol/l

—

Benign neoplasm: Rectosigmoid junction

118

1.10

0.07

1.2

1.32

1.38

nmol/l

0.07

101

Special screening examination for infectious and parasitic diseases

529

1.03

0.07

1.3

1.4

1.28

1.45

nmol/l

0.66

476

Abrasion of teeth

126

1234

1.02

0.07

1.4

1.3

1.53

1.46

nmol/l

0.25

103

1115

Abnormal findings in secretions and smears from cervix uteri vagina vulva

159

1180

1.02

0.06

1.5

1.4

1.46

1.50

nmol/l

0.19

146

1066

Other obstetric trauma

100

0.90

0.06

1.3

1.6

1.39

1.51

nmol/l

—

All dysplastic lesions of the vulva

103

0.87

0.06

2.0

1.4

1.51

1.41

nmol/l

—

Malignant neoplasm of stomach, including Hilmo

193

0.93

0.06

1.3

1.2

1.36

1.43

nmol/l

0.07

169

Hypoparathyroidism

105

0.86

0.06

1.2

1.3

1.69

1.38

nmol/l

—

Nontoxic goitre/thyroid nodule

928

1.02

0.06

1.3

1.33

1.47

nmol/l

0.68

837

Convalescence

148

1.08

0.06

1.5

1.4

1.26

1.45

nmol/l

0.37

131

Disorders of refraction and accommodation

858

1.02

0.05

1.5

1.4

1.41

1.46

nmol/l

0.20

770

Burn and corrosion of wrist and hand

110

1.09

0.05

1.3

1.21

1.43

nmol/l

0.39

Asthma and opportunity respiratory infection

120

1.08

0.05

1.1

1.2

2.07

1.47

nmol/l

0.87

107

Colorectal adenocarcinoma

673

0.98

0.04

1.3

1.2

1.21

1.44

nmol/l

1.43

606

Acute appendicitis, with complications

705

0.98

0.04

1.4

1.3

1.66

1.47

nmol/l

0.53

634

L01XE Protein kinase inhibitors

160

1.06

0.04

1.4

1.3

1.06

1.43

nmol/l

0.85

140

Presbycusis

376

1.03

0.03

1.3

1.2

1.77

1.44

nmol/l

0.84

329

Melanocytic naevi of lower limb, including hip

128

0.94

0.02

1.7

1.4

1.49

1.47

nmol/l

0.02

114

Foreign body entering into or through eye or natural orifice

251

1.04

0.02

1.3

1.40

1.39

nmol/l

0.01

227

Pleural plaque

299

0.97

0.02

1.5

1.2

1.36

1.46

nmol/l

0.26

264

Carcinoma in situ of cervix uteri

218

0.96

0.02

1.5

1.6

1.64

1.49

nmol/l

0.35

196

Pleural effusion

501

1.02

0.02

1.5

1.2

1.48

1.49

nmol/l

0.03

450

Endometriosis of ovary

450

1.02

0.02

1.3

1.4

1.68

1.36

nmol/l

0.88

397

Female genital prolapse

503

0.99

0.01

1.3

1.50

1.38

nmol/l

0.55

453

Additional codes for the location of defect, injury or illness

173

1.04

0.01

1.3

1.4

1.63

1.42

nmol/l

0.38

153

Injury of muscle and tendon at wrist and hand level

492

1.02

0.01

1.2

1.3

1.42

1.46

nmol/l

0.11

438

Melanocytic naevi of trunk

377

0.98

0.01

1.3

1.19

1.44

nmol/l

0.69

342

Other predominantly sexually transmitted diseases, not elsewhere classified

593

1.01

0.01

1.3

1.4

1.23

1.44

nmol/l

1.13

540

Alzheimer’s disease (Late onset)

502

0.99

0.01

1.2

1.04

1.47

nmol/l

4.02

446

Fracture of forearm

203

1866

1.00

0.01

1.4

1.3

1.35

1.46

nmol/l

0.76

183

1681

Symptoms and signs involving speech and voice

113

1137

0.99

0.00

1.5

1.3

1.58

1.46

nmol/l

0.48

105

1015

Cysts of oral region, not elsewhere classified

195

1.03

0.00

1.3

1.40

1.39

nmol/l

0.01

176

Malignant neoplasm, without specification of site, including Hilmo

130

1.00

0.00

1.2

1.58

1.42

nmol/l

0.24

112

Other specified disorders of external ear

111

0.99

0.00

1.3

1.2

1.07

1.49

nmol/l

1.63

100

Malignant neoplasm of oral cavity, including Hilmo

161

0.99

0.00

1.5

1.4

1.09

1.37

nmol/l

0.74

141

Vestibular neuronitis

299

1.00

0.00

1.1

1.3

1.46

1.44

nmol/l

0.04

272

Other predominantly sexually transmitted diseases, not elsewhere classified

489

1.00

0.00

1.4

1.26

1.42

nmol/l

0.73

445

Outcome of delivery

257

0.99

0.00

1.4

1.50

1.47

nmol/l

0.07

226

Other specified and unspecified disorders of eye and adnexa

103

0.97

0.00

1.1

1.3

1.82

1.36

nmol/l

—

Congenital malformations of eye, ear, face and neck

170

1.00

0.00

1.1

1.4

1.47

1.44

nmol/l

0.04

154

Congenital malformations of aortic and mitral valves

135

0.96

0.00

1.1

1.3

1.68

1.41

nmol/l

0.38

118

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.2

—

2.06

—

Idiopathic urticaria

1.00

0.00

1.6

1.3

2.20

1.35

nmol/l

—

Eclampsia

0.00

0.0

1.0

—

1.28

—

Malignant neoplasm, without specification of site

1.01

0.00

1.0

1.2

1.37

1.38

nmol/l

—

Other congenital malformations of skull and face bones

0.00

0.0

1.2

—

1.15

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.2

—

1.08

—

Malignant neoplasm of other and unspecified urinary organs

0.00

-0.00

0.0

1.0

—

1.98

—

Moyamoya

0.00

-0.00

0.0

1.2

—

1.88

—

Ankylosis of teeth

0.00

-0.00

0.0

1.4

—

1.66

—

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

0.00

-0.00

0.0

1.2

—

1.48

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.0

—

1.99

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

-0.00

0.0

1.2

—

1.01

—

Distal bite

1.01

-0.00

1.6

1.3

1.26

1.24

nmol/l

—

Folliculitis decalvans

0.00

-0.00

0.0

1.2

—

1.82

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

-0.00

0.0

1.0

—

1.11

—

Viral agents as the cause of diseases classified to other chapters

0.96

-0.00

1.1

1.2

1.01

1.39

nmol/l

—

Generalized epilepsy, strict definition

0.97

-0.00

1.0

1.3

1.62

1.31

nmol/l

—

Protozoal diseases

0.98

-0.00

1.1

1.2

1.30

1.43

nmol/l

—

Femoral hernia, unilateral

0.92

-0.00

1.1

1.2

1.56

1.50

nmol/l

—

Injury of muscle and tendon at forearm level

1.02

-0.00

1.5

1.1

2.13

1.40

nmol/l

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

1.50

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

1.84

—

Alpha thalassaemia

0.00

-0.00

0.0

1.2

—

1.72

—

Kissing spine

0.00

-0.00

0.0

1.0

—

1.10

—

Inguinal of femoral hernia, unilateral

0.92

-0.00

1.1

1.2

1.56

1.50

nmol/l

—

Crushing injury of head

0.00

-0.00

0.0

1.2

—

1.44

—

Follow-up care involving plastic surgery

0.98

-0.00

1.6

1.5

1.54

1.43

nmol/l

—

Erythrasma

0.00

-0.00

0.0

1.2

—

1.61

—

Benign neoplasm of male genital organs

0.92

-0.00

1.0

1.2

1.76

1.47

nmol/l

—

Burn and corrosion confined to eye and adnexa

0.92

-0.00

1.1

1.5

2.07

1.31

nmol/l

—

Complications specific to multiple gestation

0.00

-0.00

0.0

1.2

—

1.33

—

Alzheimer’s disease (Early onset), excluding more controls

0.93

-0.00

1.2

1.03

1.63

nmol/l

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

-0.00

0.0

1.3

—

1.84

—

Acute posthaemorrhagic anaemia

0.94

-0.00

1.1

1.2

2.39

1.54

nmol/l

—

Carcinoma in situ of larynx

0.00

-0.00

0.0

1.2

—

2.46

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.2

—

1.42

—

Procedures for purposes other than remedying health state

0.95

-0.00

1.0

1.6

1.39

1.29

nmol/l

—

Patellar tendinitis

0.96

-0.00

1.0

1.4

1.36

1.14

nmol/l

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.0

—

2.35

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.4

—

1.76

—

Rickettsioses

0.00

-0.00

0.0

1.0

—

1.70

—

Melanoma in situ of eyelid, including canthus

0.00

-0.00

0.0

1.0

—

1.87

—

Inguinal hernia, unilateral

0.92

-0.00

1.1

1.2

1.56

1.50

nmol/l

—

Short stature starting before birth

0.00

-0.00

0.0

1.3

—

0.94

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

C peptide [Moles/volume] in Serum or Plasma --post meal

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS